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A B S T R A C T
Background
Urinary incontinence can affect 40% to 60% of people admitted to hospital after a stroke, with 25% still having problems when
discharged from hospital and 15% remaining incontinent after one year.
This is an update of a review published in 2005 and updated in 2008.
Objectives
To assess the effects of interventions for treating urinary incontinence after stroke in adults at least one-month post-stroke.
Search methods
We searched the Cochrane Incontinence and Cochrane Stroke Specialised Registers (searched 30 October 2017 and 1 November
2017 respectively), which contain trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE,
MEDLINE In-Process, MEDLINE Epub Ahead of Print, CINAHL, ClinicalTrials.gov, WHO ICTRP and handsearched journals and
conference proceedings.
Selection criteria
We included randomised or quasi-randomised controlled trials.
Data collection and analysis
Two review authors independently undertook data extraction, risk of bias assessment and implemented GRADE.
Main results
We included 20 trials (reporting 21 comparisons) with 1338 participants. Data for prespecified outcomes were not available except
where reported below.
Intervention versus no intervention/usual care
Behavioural interventions:Low-quality evidence suggests behavioural interventionsmay reduce themean number of incontinent episodes
in 24 hours (mean difference (MD) -1.00, 95% confidence interval (CI) -2.74 to 0.74; 1 trial; 18 participants; P = 0.26). Further, low-
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quality evidence from two trials suggests that behavioural interventions may make little or no difference to quality of life (SMD -0.99,
95% CI -2.83 to 0.86; 55 participants).
Specialised professional input interventions:One trial ofmoderate-quality suggested structured assessment andmanagement by continence
nurse practitioners probably made little or no difference to the number of people continent three months after treatment (risk ratio
(RR) 1.28, 95% CI 0.81 to 2.02; 121 participants; equivalent to an increase from 354 to 453 per 1000, 95% CI 287 to 715).
Complementary therapy: Five trials assessed complementary therapy using traditional acupuncture, electroacupuncture and ginger-salt-
partitioned moxibustion plus routine acupuncture. Low-quality evidence from five trials suggested that complementary therapy may
increase the number of participants continent after treatment; participants in the treatment group were three times more likely to be
continent (RR 2.82, 95% CI 1.57 to 5.07; 524 participants; equivalent to an increase from 193 to 544 per 1000, 95% CI 303 to 978).
Adverse events were reported narratively in one study of electroacupuncture, reporting on bruising and postacupuncture abdominal
pain in the intervention group.
Physical therapy: Two trials reporting three comparisons suggest that physical therapy using transcutaneous electrical nerve stimulation
(TENS) may reduce the mean number of incontinent episodes in 24 hours (MD -4.76, 95% CI -8.10 to -1.41; 142 participants; low-
quality evidence). One trial of TENS reporting two comparisons found that the intervention probably improves overall functional
ability (MD 8.97, 95% CI 1.27 to 16.68; 81 participants; moderate-quality evidence).
Intervention versus placebo
Physical therapy:One trial of physical therapy suggests TPTNS may make little or no difference to the number of participants continent
after treatment (RR 0.75, 95% CI 0.19 to 3.04; 54 participants) or number of incontinent episodes (MD -1.10, 95% CI -3.99 to
1.79; 39 participants). One trial suggested improvement in the TPTNS group at 26-weeks (OR 0.04, 95% CI 0.004 to 0.41) but
there was no evidence of a difference in perceived bladder condition at six weeks (OR 2.33, 95% CI 0.63 to 8.65) or 12 weeks (OR
1.22, 95% CI 0.29 to 5.17). Data from one trial provided no evidence that TPTNS made a difference to quality of life measured with
the ICIQLUTSqol (MD 3.90, 95% CI -4.25 to 12.05; 30 participants). Minor adverse events, such as minor skin irritation and ankle
cramping, were reported in one study.
Pharmacotherapy interventions: There was no evidence from one study that oestrogen therapy made a difference to the mean number of
incontinent episodes per week in mild incontinence (paired samples, MD -1.71, 95% CI -3.51 to 0.09) or severe incontinence (paired
samples, MD -6.40, 95% CI -9.47 to -3.33). One study reported no adverse events.
Specific intervention versus another intervention
Behavioural interventions: One trial comparing a behavioural intervention (timed voiding) with a pharmacotherapy intervention (oxy-
butynin) contained no useable data.
Complementary therapy: One trial comparing different acupuncture needles and depth of needle insertion to assess the effect on
incontinence reported that, after four courses of treatment, 78.1% participants in the elongated needle group had no incontinent
episodes versus 40% in the filiform needle group (57 participants). This trial was assessed as unclear or high for all types of bias apart
from incomplete outcome data.
Combined intervention versus single intervention
One trial compared a combined intervention (sensory motor biofeedback plus timed prompted voiding) against a single intervention
(timed voiding). The combined intervention may make little or no difference to the number of participants continent after treatment
(RR 0.55, 95% CI 0.06 to 5.21; 23 participants; equivalent to a decrease from 167 to 92 per 1000, 95% CI 10 to 868) or to the
number of incontinent episodes (MD 2.20, 95% CI 0.12 to 4.28; 23 participants).
Specific intervention versus attention control
Physical therapy interventions: One study found TPTNS may make little or no difference to the number of participants continent after
treatment compared to an attention control group undertaking stretching exercises (RR 1.33, 95% CI 0.38 to 4.72; 24 participants;
equivalent to an increase from 250 to 333 per 1000, 95% CI 95 to 1000).
Authors’ conclusions
There is insufficient evidence to guide continence care of adults in the rehabilitative phase after stroke. As few trials tested the same
intervention, conclusions are drawn from few, usually small, trials. CIs were wide, making it difficult to ascertain if there were clinically
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important differences. Only four trials had adequate allocation concealment and many were limited by poor reporting, making it
impossible to judge the extent to which they were prone to bias. More appropriately powered, multicentre trials of interventions are
required to provide robust evidence for interventions to improve urinary incontinence after stroke.
P L A I N L A N G U A G E S U M M A R Y
Treatments for urinary incontinence after stroke in adults
Review question
We wanted to assess the effectiveness of interventions aimed at helping urinary incontinence in adults who had a stroke more than one
month before.
Background
Half of people admitted to hospital with a stroke have urinary incontinence. As well as involuntary loss of urine, symptoms of
urinary incontinence include having an urgent desire to pass urine (urge incontinence) or leaking urine when laughing or sneezing
(stress incontinence). These symptoms are more severe in stroke survivors than in other people with urinary incontinence. They cause
embarrassment and distress and affect people’s ability to take part in rehabilitation. Urinary incontinence reduces feelings of self-worth
and depression is common. It also has a major impact on families and may affect whether patients are able to return home.
Search date
The search is current to 1 November 2017.
Study characteristics
We identified 20 studies identifying 21 comparisons and involving 1338 people. These studies included a variety of behavioural therapies
(e.g. pelvic floor muscle training), complementary therapies (e.g. manual acupuncture or electroacupuncture) and physical therapies
(e.g. transcutaneous electrical nerve stimulation, TENS), as well as medicines (e.g. oxybutynin, oestrogen). One trial investigated the
effect of assessment and treatment by a continence nurse practitioner. Control groups were generally ’usual care’ or no treatment.
Key results
We found that behavioural interventions may reduce the mean number of incontinent episodes in 24 hours but may make little or no
difference to quality of life. However, intervention from a continence nurse practitioner probably made little or no difference to the
number of people continent three months after treatment. Complementary therapies such as acupuncture may increase the number of
participants continent after treatment. Physical therapies, such as transcutaneous electrical nerve stimulation, may reduce the average
number of incontinent episodes in 24 hours and probably improves functional ability.
Quality of the evidence
The quality of the evidence was limited due to poor reporting of study details (particularly in the earlier studies) and the small number
of study participants in most comparisons. More than half of the studies did not provide information on side effects.
Authors’ conclusions
High-quality trials comparing different treatments to usual care or no treatment involving larger numbers of participants are needed.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Behavioural interventions compared with usual care or no treatment for treating urinary incontinence after stroke
Patient or population: people with stroke and urinary incont inence
Settings: hospital, clinic or home
Intervention: behavioural intervent ions
Comparison: no treatment/ usual care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Intervention
Number of participants
continent after treat-
ment
Study population - - - Not reported
- -
Number of incontinent
episodes
The mean number of
incont inent episodes in
the control group was
1.2
The mean number of
incont inent episodes in
the intervent ion group
was 0.2
MD -1.00
(-2.74 to 0.74)
18 part icipants (1) ⊕⊕©©
Lowa
Outcome reported de-
script ively for Tibaek
2017: the reported num-
ber of UI episodes per
24 hours was very small
(intervent ion 0 at post-
test and 1 at follow-up;
control 0 at post-test, 0
at follow-up)
Perception of improve-
ment or cure
- - - - - Not reported
Health status and qual-
ity of life
assessed by Bristol
Female Lower Urinary
Tract Symptoms Ques-
The mean quality of lif e
score ranged across
control groups f rom 39.
08 to 47
The mean quality of lif e
score in the interven-
t ion groups was
24.38 to 44
SMD -0.91
(-1.50 to -0.32)
55 part icipants (2) ⊕⊕©©
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t ionnaire (quality of
lif e items, score range
0, best case, to 18,
worst case); mean to-
tal score Incont inence
Impact Quest ionnaire
(each subscale score
ranged f rom 0, best
case, to 100, worst
case)
Functional ability - - - - - Not reported
Adverse events - - - - - Not reported.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; MD: mean dif ference; SMD: standardised mean dif ference; UI: urinary incont inence.
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aDowngraded by one level for study design (allocat ion concealment unclear), and by one level for imprecision: fewer than 100
part icipants.
bDowngraded by one level for study design (allocat ion concealment unclear in 2/ 2 trials in the meta-analysis), and by one
level for imprecision: fewer than 100 part icipants in both studies.
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B A C K G R O U N D
Urinary incontinence (UI) may affect around half of stroke sur-
vivors in the acute phase of stroke recovery (during the first
month). A significant proportion of stroke survivors, just less than
half, will still be incontinent at three months and just over one-
third of stroke survivors will remain incontinent at 12 months
after stroke. This review focused on interventions for UI in stroke
survivors who were at least one month post-stroke and consid-
ered to be in the rehabilitative phase of stroke recovery. A review
is planned for interventions for stroke survivors with UI in the
first month after stroke and considered to be in the acute phase of
stroke recovery.
Description of the condition
UI is defined as the complaint of any involuntary leakage of urine
(Abrams 2002). Up to 53% of stroke survivors report UI at four
weeks after stroke (Kolominsky-Rabas 2003). As many as 44% of
stroke survivors are incontinent at three months post-stroke and
38% at one year after stroke (Williams 2012). UI often presents as
a new problem after stroke or, if pre-existing, worsens significantly,
adding to the disability and helplessness caused by neurological
deficits (Brittain 2000a). The more severe the stroke, the greater
the likelihoodofUI (Brittain 1998b; Burney 1996a).Other factors
include older age, female sex, speech difficulties, motor weakness,
visual field defects or cognitive impairment (Barrett 2002).
Several studies have identified damage to the frontal lobe, the area
believed to be responsible for control of micturition, as associated
with urinary dysfunction after stroke. However, evidence suggests
that the size of the lesion, rather than its location, is more likely to
predict UI (Brittain 1999). It is unclear whether incontinence is
a direct (i.e. site of brain lesion) or indirect (e.g. motor, visual or
speech problemsmaking the task of accessing toilet facilities a chal-
lenge) consequence of stroke. Other non-neurological factors con-
tributing to UI, including premorbid continence state, sphincter
incompetence and polyuria (Barrett 2002), are regarded as preva-
lent in the population of people with stroke (Brittain 1998b).
Problems experienced may range from urinary retention to com-
plete incontinence. The most likely pattern of incontinence is uri-
nary frequency, urgency (a sudden compelling desire to pass urine
which is difficult to defer) and urge incontinence (involuntary
leakage) (Marinkovic 2001). This is generally the result of detru-
sor overactivity (Talwar 1993), although this may depend on the
site of the stroke lesion (Burney 1996b).
It is important to study UI in this population as symptoms are
more severe andhavemore of an effect comparedwith other groups
of people (Brittain 2000a). Incontinence is not just a physical
problem but impacts on what people can do and how they feel (
Williams 1993).Depression is twice as common in stroke survivors
who are incontinent compared with those who are continent (
Brittain 1998a; Limampai 2017).Negative social consequences for
survivors and carers cannot be ignored; both may become isolated
and marginalised (Brittain 2007).
Continuing incontinence is associated with poor outcome in
both stroke survivors and carers (Arkan 2018; Nakayama 1997;
Pettersen 2006; Tseng 2015). Conversely, stroke outcome is bet-
ter in those stroke survivors who remain continent or regain
continence (Barer 1989). Improvement is common over time
(Marinkovic 2001), which suggests that problems with continence
may be transient in some stroke survivors or amenable to inter-
vention, or both. Factors predicting early improvements in conti-
nence status are less impairment on admission and the site of the
stroke lesion (Ween 1996). Factors associated with poor recovery
of continence include stroke type and being aged 75 or over (Patel
2001).
Incontinence is a strong predictor of stroke functional outcome
(Meijer 2003). While there are problems with attributing better
stroke outcome to improvements in continence, it is possible that
recovery from incontinence may improve morale and self-esteem
and, therefore, speed overall stroke recovery (Barer 1989; Patel
2001).
Description of the intervention
Current guidelines for the management of UI recommend an as-
sessment to guide management (Intercollegiate Stroke Working
Party 2016). This begins with physical assessment and history-
taking, including identification of urological problems before the
stroke occurred such as bladder outlet obstruction or stress in-
continence. The choice of method to promote continence will
then depend on the person’s history and type of incontinence. Be-
havioural interventions are recommended as first-line therapy for
managing UI (NICE 2012). These include interventions designed
to promote continence, for example bladder training (appropriate
for urge incontinence) and pelvic floor muscle training (appropri-
ate for stress incontinence (Hay-Smith 2011)), and toileting as-
sistance programmes such as prompted or timed voiding or habit
retraining. These are designed to minimise incontinence episodes
and are appropriate for people experiencing problems after stroke
such as memory loss or restriction of movement (Eustice 2000;
Ostaszkiewicz 2004a; Ostaszkiewicz 2004b; Roe 2007).
Other management techniques include: specialised professional
input interventions (e.g. specialist continence advisors); com-
plementary therapy interventions (e.g. acupuncture; Lim 2015);
homeopathy; drug treatments (e.g. anticholinergics; Nabi 2006);
physical therapies (e.g. electrical stimulation); physical aids (e.g.
pessaries) and environmental or lifestyle interventions (e.g. diet
and fluid management).
How the intervention might work
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Behavioural interventions
Behavioural interventions are recommended as a first-line ther-
apy for managing UI (NICE 2012). Bladder training aims to help
people regain bladder control and continence through individu-
alised voiding regimens designed to restore regular, normal void-
ing patterns by progressively lengthening the time interval be-
tween voids. PFMT involves contracting the pelvic floor muscles,
raising the position of the levator ani muscles through increased
volume and muscle stiffness, and, through this, providing more
support to the bladder neck and proximal urethra (Ayeleke 2015).
The duration, number and intensity of pelvic muscle floor con-
tractions required to successfully treat UI is unclear. Timed void-
ing, prompted voiding and habit retraining (individualised toi-
leting patterns) are examples of other behavioural interventions
(International Continence Society 2015).
Specialised professional input interventions
Specialised professional input interventions may include conti-
nence services provided by specialist nursing or continence teams
in either a community or hospital setting. Professionals may in-
clude a range of staff, including general practitioners (GPs), con-
tinence nurse practitioners (CNPs), continence advisors, phys-
iotherapists or occupational therapists. Individualised care path-
ways are implemented following holistic and in depth assessment,
which may include urodynamic investigations. Interventions may
include education or behavioural components.
Complementary therapy interventions
Complementary therapy interventions include acupuncture or
homeopathy. Traditionally, acupuncture has been used in the treat-
ment of pain relief (Paik 2013); this treatment method is now
used for UI (Song 2011). In clinical practice, traditional man-
ual acupuncture or electroacupuncture are the most commonly
used techniques (Ju 2017), which involve the stimulation of spe-
cific acupuncture points on the skin by using thin disposable nee-
dles (VanderPloeg 2009). In treatment for the urinary system,
acupuncture exerts an influence on both the autonomic and so-
matic nervous systems that control the muscles used in micturi-
tion and control UI (Paik 2013). The detrusor muscle is relaxed
by sympathetic stimulation originating in the lumbar spinal cord
region (T11-L2) and contracted by parasympathetic stimulation
from the sacral spinal cord region (S2-4) (Paik 2013). The exter-
nal urethral sphincter is under somatic control (Shefchyk 2001).
Therapists report stimulating multiple acupoints in the treatment
of UI (sacral, abdominal or leg regions of the body) but there is
inconsistency in the depth of acupuncture (Paik 2013).
Pharmacotherapy interventions
Pharmacotherapy interventions may include anticholinergics (an-
timuscarinic agents), adrenergics or hormonal treatment. Anti-
cholinergic drugs treat symptoms of overactive bladder, includ-
ing incontinence, and act by decreasing the spontaneous muscle
spasms of the bladder (Kuteesa 2006). Adrenergic agonists (al-
pha and beta) may be of benefit in promoting continence in the
lower urinary tract by exerting effects on the contraction strength
of the bladder neck and urethral sphincter muscle (alpha). Beta-
adrenergics may promote continence through effects of the relax-
ation of the detrusor muscle, with or without contraction of the
urethral sphincter (Alhasso 2005). Hormonal (oestrogen) therapy
administered locally or systemically, may be prescribed for post-
menopausal women and may help to keep the bladder and urethra
healthy and functioning properly (Cody 2012). Oestrogen cream
may help some women with UI by reversing atrophic vaginitis
and urethritis. The effect of hormonal treatments in people post-
stroke is unclear.
Physical therapy interventions
Physical therapy interventions include electrical stimulation or
biofeedback. Neuromodulation of the sacral nerve plexus using
electrical stimulation is an effective treatment to alleviate overac-
tive bladder and urge UI (Staskin 2012). However, such an ap-
proach has not been previously tested in the stroke population.
Electrically stimulating the sacral nerve plexus neuromodulates
the L4-S3 nerve roots that control bladder function and urethral
sphincter activity to eliminate inappropriate detrusor contractions
while leaving the micturition reflex intact. Transcutaneous poste-
rior tibial nerve stimulation (TPTNS) is a technique of non-in-
vasive retrograde electrical stimulation of the sacral plexus via the
sciatic nerve. The posterior tibial nerve, a tributary of the sciatic
nerve, is accessed using surface electrodes applied to the medial
malleolar area.
Physical aids
Physical aids are used to stop or control urinary leakage and include
intravaginal devices (pessaries). Pessaries are used in stress UI to
support the bladder neck. Some devices include a knob which
compresses the urethra against the pubic bone to prevent leakage
when intra-abdominal pressure increases (Al-Shaikh 2018).
Environmental or lifestyle interventions
Nutritional andmetabolicmechanisms can affect the urinary tract.
Lifestylemodifications (e.g. fluid and caffeine intake, smoking ces-
sation, weight loss) may reduce UI. For example, weight loss may
reduce higher intra-abdominal pressure associated with obesity
through strengthening pelvic floor support structures (Imamura
2015).
Why it is important to do this review
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This review aimed to evaluate the effects of a range of interventions
designed to improve UI at least one month post-stroke by assess-
ing the evidence available from randomised and quasi-randomised
controlled trials. Current clinical guidelines are largely based on ex-
pert consensus (Intercollegiate StrokeWorking Party 2016); there
is little evidence of the effectiveness of interventions recommended
(e.g. timed voiding, prompted voiding, bladder training) with the
stroke population.
O B J E C T I V E S
To assess the effects of interventions for treating urinary inconti-
nence after stroke in adults at least one month post-stroke.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised and quasi-randomised trials evaluating
the effects of interventions designed to promote continence in
people who have had a stroke. Quasi-random methods include
allocation by the person’s date of birth, by the day of the week
or month of the year, by a person’s medical record number or
allocating every alternate person.
Types of participants
Adults (i.e. 18 years of age and over) with a diagnosis of stroke,
including people with incontinence who have had a stroke iden-
tified as a subgroup within a larger group for whom relevant data
were reported.
Types of interventions
One armof the studymust have included an intervention designed
to promote urinary continence. We included trials evaluating any
of the following in this review:
• behavioural interventions, for example prompted or
scheduled voiding, bladder training, habit retraining (i.e.
identification of voiding pattern and development of an
individualised toileting schedule), PFMT or other behavioural
management programmes;
• specialised professional input interventions, for example
provision of information or education, assessment schedules,
generic multidisciplinary rehabilitation programmes, continence
advisors, home-support programmes or CNPs;
• complementary therapy interventions, for example
homeopathy, acupuncture (traditional manual acupuncture or
electroacupuncture);
• pharmacotherapy interventions, for example
anticholinergics, adrenergics, hormonal treatment;
• physical therapy interventions, for example electrical
stimulation, biofeedback;
• physical aids, for example pessaries, other appliances; and
• environmental or lifestyle interventions, for example
voiding position, diet and fluid management.
Acceptable control interventions were usual care, no treatment,
placebo or attention control (clinical attention in the form of
an intervention inducing an expectation of therapeutic benefit;
Freedland 2011). We believe that the comparison of particular in-
terest to patients and practitioners in this review is intervention
versus no intervention/usual care.
We excluded trials relating solely to surgical or physical interven-
tions for pre-existing continence problems that were not associated
with stroke (e.g. transurethral resection of the prostate) unless it
was a cointervention in a wider trial testing an included method
of continence promotion. We excluded trials relating to urological
diagnosis, or to the management of incontinence or retention of
urine in the acute phase of stroke (defined as up to one-month
post-stroke). We also excluded trials if continence was not mea-
sured either by reporting participant symptoms or by a physical
measure (e.g. a pad test).
Types of outcome measures
Primary outcomes
• Continence, measured by the following.
◦ Number of participants continent after treatment
◦ Number of incontinent episodes (indicated by bladder
charts, total and mean number of episodes)
◦ Perception of improvement or cure (as reported by
participant or carer)
Secondary outcomes
• Urinary symptoms, including frequency, urgency, nocturia
• Physical measures (e.g. pad tests of quantified leakage, post-
void retention of urine, void volume, urodynamic measures)
• Health status and quality of life (impact of incontinence
e.g. Incontinence Impact Questionnaire (IIQ), 36-Item Short
Form Health Survey Questionnaire (SF-36), Bristol Female
Urinary Symptoms Questionnaire, knowledge, quality of life)
• Functional ability (activities of daily living e.g. Barthel
Index)
• Participant satisfaction
• Adverse events
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’Summary of findings’ tables
We used GRADE to interpret findings and to create ’Summary of
findings’ tables for the main comparison (intervention versus no
intervention/usual care) using the outcomes below for behavioural
interventions, specialised professional input, complementary ther-
apy and physical therapy:
• number of participants continent after treatment;
• number of incontinent episodes in 24 hours;
• perception of improvement or cure;
• health status and quality of life;
• functional ability; and
• adverse events.
We chose outcomes for the ’Summary of findings’ tables based
on the primary outcomes, outcomes of clinical importance, and
outcomes of most importance to patients.
Search methods for identification of studies
We imposed no language or other restrictions on any of the
searches.
Electronic searches
We used the search strategies developed for both Cochrane Incon-
tinence and Cochrane Stroke.We initially identified relevant trials
from the Groups’ Specialised Registers of controlled trials.
For more details of the search methods used to build the Cochrane
Incontinence Specialised Register, see the Group’s webpages where
details of the Register’s development (from inception) and the
most recent searches performed to populate the Register can be
found. For more details of the search methods used to build the
Cochrane Stroke Specialised Register, see the Cochrane Stroke
webpages.
To summarise, both Registers contain trials identified from the
Cochrane Central Register of Controlled Trials (CENTRAL),
MEDLINE, MEDLINE In-Process, MEDLINE Epub Ahead of
Print, CINAHL, ClinicalTrials.gov, WHO ICTRP, UK Clinical
Research Network Portfolio, and handsearching of journals and
conference proceedings. TheCochrane Stroke SpecialisedRegister
includes searches of many other sources of trials.Many of the trials
in the Cochrane Incontinence and Cochrane Stroke Specialised
Registers are also contained in CENTRAL. The dates of the most
recent searches of the Specialised Registers for this review update
were: 30 October 2017 (Cochrane Stroke Register) and 1 Novem-
ber 2017 (Cochrane Incontinence Register).
The terms used to search the Cochrane Incontinence and
Cochrane Stroke Specialised Registers are given in Appendix 1.
For the first two versions of this review, extra specific searches
were performed (Thomas 2005; Thomas 2008). For more details,
including the search terms used, see Appendix 2.
Searching other resources
We searched the reference lists of all relevant reviews and trial
reports to identify further relevant studies.
Data collection and analysis
Selection of studies
Two review authors (of LT, JC and LC) independently screened
titles and abstracts for potentially eligible studies. We resolved any
disagreements regarding the inclusion or exclusion of individual
studies by discussion or, if necessary, by consulting the third review
author. We contacted authors of identified articles where there
were missing or unclear data in order to inform study selection
decisions. There was no masking of the source and authorship of
the trial reports.
Data extraction and management
Pairs of review authors (of LT, JC and LC) performed independent
data extraction of the included trials using a piloted data collection
form. The data collected included information on study design,
study population, interventions, outcomes measurement and re-
sults. We resolved any discrepancies in data extraction either by
discussion between the two authors or with involvement of the
third review author. Two review authors (LT and JC) entered data
into Review Manager 5 (Review Manager 2014).
Assessment of risk of bias in included studies
Two review authors (LT and JC) independently assessed the risk
of bias of included studies using Cochrane’s ’Risk of bias’ tool
(Higgins 2011). The tool covers the domains of random sequence
generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessment, incomplete outcome
data, selective outcome reporting and other bias.We classified each
domain as either low risk, high risk or unclear risk of bias.
Measures of treatment effect
We based analyses on available data from all included trials rele-
vant to the comparisons and outcomes of interest. We summarised
effect estimates for continuous outcomes using mean difference
(MD) and we summarised dichotomous outcomes using risk ratio
(RR). For continuous outcome data, we used MD of post-treat-
ment scores unless changes from baseline data were available.
Unit of analysis issues
For cross-over trials, we analysed the data using a paired samples
mean and SE test.We analysedmulti-arm trials comparing two in-
terventions arms with one control group using methods described
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by Higgins 2011 (section 16.5.4). To prevent inappropriate dou-
ble-counting of individuals, we analysed each treatment arm sep-
arately against the common control group but divided the sample
size of the common comparator group proportionately across each
intervention comparison.
Dealing with missing data
We attempted to obtain missing data, as well as data collected but
not reported, by contacting trialists. We contacted study authors
of trials which included a subgroup of people with stroke to ob-
tain stroke subgroup data. If no response was received from study
authors after one contact, we made a second request to obtain the
required data.
Assessment of heterogeneity
We only combined and pooled data from trials if the types of in-
terventions were similar enough to do so. We investigated differ-
ences between trials if heterogeneity (I²) was greater than 50%.
If heterogeneity could not be explained, we considered using a
random-effects model.
We described the statistical heterogeneity of the intervention ef-
fects by calculating the I² statistic and using the Chi² test. We
interpreted heterogeneity as follows.
• 0% to 40%: represents low heterogeneity.
• 30% to 60%: may represent moderate heterogeneity.
• 50% to 90%: may represent substantial heterogeneity.
• 75% to 100%: represents considerable heterogeneity.
We used both random-effects and fixed-effect meta-analysis with
95% CI using Review Manager (Review Manager 2014). We
pooled outcomes such as quality of life measured with different
instruments using the standardised mean difference (SMD).
Assessment of reporting biases
We searched clinical trial registers to assist in reducing publication
bias. We also investigated selective outcome reporting though the
comparison of the methods section of papers with the results re-
ported.
Data synthesis
Dichotomous outcomes reported as favourable events were the
number of people continent after treatment and participant satis-
faction. Outcomes reported as unfavourable events were number
of incontinence episodes in 24 hours, urinary symptoms (includ-
ing frequency, urgency, nocturia) and adverse events.
We summarised effect estimates for continuous outcomes using
MD or SMD and we summarised dichotomous outcomes using
RR. Where deemed appropriate, we pooled effects across similar
studies using fixed- or random-effects meta-analysis techniques
with 95% confidence intervals (CIs). We used random-effects
meta-analysis (DerSimonian 1986) if the studies showed hetero-
geneity (defined by the studies’ effects having an I² statistic of
greater than 50%); otherwise, we used a fixed-effect analysis (Man-
tel-Haenszel method) for dichotomous and inverse variance for
continuous data (Mantel 1959). For continuous outcome data,
we used change from baseline data if available; otherwise, we used
the raw outcome data.
Subgroup analysis and investigation of heterogeneity
Where data were available, we planned subgroup analyses for
the effect of urological diagnosis (i.e. detrusor overactivity versus
other) and time from stroke onset to recruitment to trial.
Sensitivity analysis
Where data allowed, we planned to explore the effects of includ-
ing studies assessed as having a high risk of bias using sensitivity
analyses.
’Summary of findings’ tables
We prepared ’Summary of findings’ tables for the main compar-
ison. To ensure clarity, we created individual ’Summary of find-
ings’ tables for specific clinically important interventions within
the main comparison.
Three review authors (LT, JC, LC) assessed and documented the
quality of evidence for the prespecified outcomes outlined in the
Types of outcome measures based on the GRADE approach (
Guyatt 2008). We downgraded the evidence from high-quality
by one level for serious (or by two levels for very serious) study
limitations:
• risk of bias due to flawed design or conduct of studies
(random sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assessment,
and incomplete outcome data). We reassessed all studies from
the original review (Thomas 2008) using the updated ’Risk of
bias’ tool (Higgins 2011);
• imprecision (e.g. when CIs for treatment effect were wide);
• inconsistency (e.g. when point estimates varied widely, the
I² was large);
• indirectness (e.g. variations in participants, interventions,
comparisons and outcomes); and
• publication bias (may be explored with the use of funnel
plots and classed as not suspected, suspected, strongly suspected
or very strongly suspected).
R E S U L T S
Description of studies
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Results of the search
Search for the 2019 review update
The previous version of this review included 12 studies (Thomas
2008). The search for the 2019 version identified a further 10
studies (Booth 2016; Chu 2011; Guo 2014; Liu 2013; Liu 2016a;
Liu 2016b;Monteiro 2014; Shin 2016a; Song 2013; Tibaek 2017;
Zhang 1996; see Figure 1). One review author (AT) translated
studies published in Chinese. Two studies were reported in the
same conference abstract (Gelber 1997a; Gelber 1997b). Two tri-
als originally included in the 2008 version were removed from
this update as they were found not to be eligible (Wikander 1998;
Zhu 2003). Two studies previously classified as awaiting assess-
ment were excluded in this version as stroke subgroup data were
not available (Engberg 2002;McDowell 1999).We identified two
potentially relevant studies that are still ongoing (NCT02568774;
Shin 2016b). We classified three studies as awaiting further as-
sessment (ACTRN12617000162314; ChiCTR-INR-16010239;
Wang 2014).
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Figure 1. PRISMA study flow diagram (2019 review update).
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Therefore, the review has 20 included studies (reporting 21 com-
parisons), 27 excluded studies, two ongoing studies and three stud-
ies awaiting classification.
Appendix 3 shows the results of the search for the previous versions
of this review (Thomas 2005; Thomas 2008).
Included studies
For details about the included studies, please see theCharacteristics
of included studies. Please note: Liu 2016a and Liu 2016b are two
arms of a multi-arm RCT reporting on two separate comparisons.
Henceforth, they are listed below as “Liu 2016a and Liu 2016b”
to highlight their relation to one another.
Design
Of the 20 included trials, all were randomised controlled trialswith
the exception of Booth 2016, which was a randomised controlled
feasibility trial and Judge 1969, which was a cross-over trial. The
trial by Liu was a three-arm trial (Liu 2016a and Liu 2016b). All
trials were single-centre with the exception of Booth 2016 and
Song 2013.
Study funding sources
Twelve studies did not publish a funding statement (Chu 1997;
Chu 2011; Gelber 1997a; Gelber 1997b; Guo 2014; Lewis 1990;
Liu 2006;Monteiro 2014; Song 2013; Zhang 1996; Zhang 2002;
Zhou 1999). Two studies reporting three comparisons reported
that they received no funding grants (Liu 2016a and Liu 2016b;
Shin 2016a). Six studies reported funding sources (Booth 2016;
Brittain 2000b; Judge 1969; Liu 2013; Tibaek 2005; Tibaek
2017).
Study dates
Publication dates of the trials ranged from 1969 to 2016. Six
studies did not report information on the period when partici-
pants were recruited to the trials or the dates the studies were con-
ducted (Gelber 1997a; Gelber 1997b; Judge 1969; Lewis 1990;
Shin 2016a; Zhang 1996). Five trials reported the study period
as occurring between 1992 and 2001 (Brittain 2000b; Chu 1997;
Tibaek 2005; Zhang 2002; Zhou 1999). One trial was conducted
between 2004 and 2006 (Liu 2006). Four trials were conducted
between 2007 and 2012 (Liu 2013; Monteiro 2014; Song 2013;
Tibaek 2017). One trial was conducted between 2014 and 2016
(Booth 2016). One trial reported recruitment from hospital in-
patients during the period 2007 to 2010 (Chu 2011). One trial
reported hospitalisation dates of participants between 2010 and
2011 (Guo 2014). Liu 2016a and Liu 2016b reported that par-
ticipants were in hospital between 2011 and 2013.
Sample sizes
Three trials included fewer than 25 participants (Judge 1969;
Lewis 1990; Monteiro 2014). Five trials included between 26
and 49 participants (Gelber 1997a; Gelber 1997b; Shin 2016a;
Tibaek 2005; Tibaek 2017). Eleven trials, including one trial that
reported two comparisons, had 50 or more participants (Booth
2016; Brittain 2000b;Chu1997;Chu 2011;Guo 2014; Liu 2006;
Liu 2013; Liu 2016a and Liu 2016b; Zhang 1996; Zhang 2002;
Zhou 1999).
Setting
Of the 20 trials, 10 were carried out in China, including one
trial that reported two comparisons (Chu 1997; Chu 2011; Guo
2014; Liu 2006; Liu 2013; Liu 2016a and Liu 2016b; Song 2013;
Zhang 1996; Zhang 2002; Zhou 1999), one in England (Brittain
2000b), two in Scotland (Booth 2016; Judge 1969), three in the
USA (Gelber 1997a; Gelber 1997b; Lewis 1990), one in Brazil
(Monteiro 2014), one inKorea (Shin 2016a), and two inDenmark
(Tibaek 2005; Tibaek 2017).
Six trials took place in an outpatient setting (Guo 2014; Liu
2013; Monteiro 2014; Shin 2016a; Tibaek 2005; Tibaek 2017).
One trial took place in a long-stay inpatient setting for elderly
people (Judge 1969). Two trials took place in an inpatient setting
(Liu 2006; Zhang 1996), and two trials, including one trial that
reported two comparisons, were conducted in both an inpatient
and outpatient setting (Liu 2016a and Liu 2016b; Song 2013).
Two trials took place in participants’ homes in the community
(Booth 2016; Brittain 2000b). The remaining trials did not specify
the location of care (Chu 1997; Chu 2011; Gelber 1997a; Gelber
1997b; Lewis 1990; Zhang 2002; Zhou 1999).
Participants
The 20 trials included 1338 participants. The numbers of partic-
ipants in the individual trials ranged from 12 to 232. Twelve tri-
als, including one trial reporting two comparisons, included both
genders (Booth 2016; Brittain 2000b; Chu 1997; Chu 2011; Guo
2014; Liu 2006; Liu 2013; Liu 2016a and Liu 2016b; Song 2013;
Zhang 1996; Zhang 2002; Zhou 1999). Five trials included only
women (Judge 1969; Shin 2016a; Tibaek 2005), or only men
(Monteiro 2014; Tibaek 2017). Three trials did not report gender
characteristics (Gelber 1997a; Gelber 1997b; Lewis 1990).
Three trials did not report the age of the participants (Gelber
1997a;Gelber 1997b; Lewis 1990). Six trials reported an age range
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of participants (Brittain 2000b: 40 to 96 years; Chu 1997: 45 to
71 years; Judge 1969: 66 to 92 years; Zhang 1996: 52 to 78 years;
Zhang 2002: 42 to 62 years; Zhou 1999: 52 to 85 years). Eleven
trials reported themean and standard deviation (SD) of the ages of
the participants in both the intervention and control groups. Of
these, eight had a mean age in the intervention group of 62 to 68
years, including one trial that reported two different comparisons
(Booth 2016; Chu 2011; Guo 2014; Liu 2006; Liu 2016a and
Liu 2016b;Monteiro 2014; Shin 2016a; Tibaek 2017). Two trials
reported a lower mean age in the intervention group: Liu 2013
(mean age 39 years) and Song 2013 (mean age 55 years). One trial
reported a median age of 60 years (interquartile range (IQR) 56
to 74 years) (Tibaek 2005).
Eleven trials reported both inclusion and exclusion criteria, in-
cluding one trial that reported two different comparisons (Booth
2016; Brittain 2000b; Guo 2014; Liu 2006; Liu 2013; Liu 2016a
and Liu 2016b; Monteiro 2014; Shin 2016a; Song 2013; Tibaek
2005; Tibaek 2017). Seven trials did not report any inclusion and
exclusion criteria (Chu 1997; Gelber 1997a; Gelber 1997b; Lewis
1990; Zhang 1996; Zhang 2002; Zhou 1999). One trial reported
exclusion criteria only (Judge 1969), while one trial reported in-
clusion criteria only (Chu 2011).
Six trials, including one trial reporting two comparisons, included
participants with either a first or recurrent stroke (i.e. only includ-
ing participants after a first stroke was not mentioned in either in-
clusion or exclusion criteria) (Booth 2016; Guo 2014; Liu 2016a
and Liu 2016b; Monteiro 2014; Shin 2016a; Tibaek 2017). With
the exception of Tibaek 2005, it was not possible to determine
whether only participants with a first stroke were included in the
remaining trials.
Interventions
The trials tested the following interventions.
Behavioural interventions (five trials):
• timed voiding versus void on request (Gelber 1997a);
• timed voiding versus oxybutynin (Gelber 1997b);
• PFMT versus usual care (Shin 2016a; Tibaek 2005; Tibaek
2017).
Specialised professional input interventions (one trial):
• care from a CNP versus usual care provided by the GP
(Brittain 2000b).
Complementary therapy interventions (eight trials):
• scalp acupuncture versus no scalp acupuncture (Chu 1997);
• eye acupuncture and scalp electroacupuncture versus herbal
medication therapy (Zhou 1999);
• traditional acupuncture (knee and inside of ankle) versus
usual care (Zhang 2002);
• pelvic plexus acupuncture versus filiform needle (Zhang
1996);
• ginger-salt-partitioned moxibustion (involving filling the
navel with salt, adding a piece of ginger and a taper and setting
the taper alight) plus routine acupuncture versus routine
acupuncture (Liu 2006);
• electroacupuncture (lumbar and sacral region) versus
standard medical therapy and scalp and body acupuncture (Chu
2011);
• electroacupuncture combined with traditional acupuncture
(sacral region) versus sham acupuncture (sacral region) (Liu
2013);
• electroacupuncture (multiple points on arms, legs and
torso) versus indwelling catheter with bladder training (Song
2013).
Pharmacotherapy interventions (one trial):
• oestrogen versus placebo (Judge 1969).
Physical therapy interventions (five trials reporting six compar-
isons):
• sensory-motor biofeedback device (Uristop) combined with
timed voiding against timed voiding alone (Lewis 1990);
• transcutaneous posterior tibial nerve stimulation (TPTNS)
versus sham (Booth 2016), or versus attention control (Monteiro
2014);
• transcutaneous electrical nerve stimulation (TENS) versus
usual care (Guo 2014), no treatment control or a different
frequency of stimulation (Liu 2016a and Liu 2016b).
We found no trials evaluating interventions that included physical
aids, or environmental or lifestyle interventions.
Intervention comparisons
The effects of the included intervention types (behavioural, spe-
cialised professional input, complementary, pharmacotherapy and
physical therapy) were considered within the following five com-
parison categories:
• intervention versus no intervention/usual care;
• intervention versus placebo;
• specific intervention versus another intervention;
• combined intervention versus single intervention;
• specific intervention versus attention control.
Intervention versus no intervention/usual care
Twelve trials tested an intervention versus no intervention or
usual care, including one trial reporting two comparisons (Brittain
2000b; Chu 1997; Gelber 1997a; Guo 2014; Liu 2006; Liu 2016a
and Liu 2016b; Shin 2016a; Song 2013; Tibaek 2005; Tibaek
2017; Zhang 2002; Zhou 1999).
Behavioural interventions
One trial tested a behavioural intervention comprising timed void-
ing versus void on request for participants with normal urody-
namic studies (Gelber 1997a). Normal urodynamic studies were
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not defined and no further details were given of the intervention.
Two trials tested an intensive PFMT programme, comprising in-
dividual and group exercises and feedback to participants, com-
pared with normal rehabilitation with no specific treatment of UI
(Tibaek 2005; Tibaek 2017). One trial evaluated PFMT in addi-
tion to general rehabilitation training compared with general re-
habilitation training alone (Shin 2016a).
Specialised professional input interventions
One trial tested a specialised professional input intervention com-
paring care given by a CNP versus usual care provided by a GP
and existing specialised services for themanagement of continence
(Brittain 2000b).
Complementary therapy interventions
Five trials tested complementary interventions: Chu 1997 tested
scalp acupuncture plus usual care versus usual care; Zhang 2002
tested acupuncture versus general treatment; and Zhou 1999
tested eye and scalp electroacupuncture versus herbal medication
therapy only, which we classed as usual care. Liu 2006 tested gin-
ger-salt-partitioned moxibustion plus routine acupuncture versus
routine acupuncture. Song 2013 compared electroacupuncture
versus indwelling catheter.
Physical therapy interventions
Two trials tested transcutaneous electrical nerve stimulation. In
one trial, the comparison group received “basic therapy” (Guo
2014). The other trial, reporting two comparisons, compared dif-
ferent electrical frequencies against no treatment (Liu 2016a and
Liu 2016b).
Intervention versus placebo
One cross-over trial tested a pharmacotherapy intervention (oe-
strogen) versus placebo (Judge 1969).
One feasibility trial compared TPTNS versus a sham intervention
with electrodes positioned to avoid the tibial nerve (Booth 2016).
One trial compared electroacupuncture trial combined with tra-
ditional acupuncture with sham acupuncture (Liu 2013).
Specific intervention versus another intervention
Gelber 1997b tested a specific intervention against another inter-
vention, comparing the anticholinergic oxybutynin versus timed
voiding in participants with bladder hyper-reflexia. Zhang 1996
tested acupuncture with an elongated needle compared with a fil-
iform needle.
Combined intervention versus single intervention
One trial tested a combined intervention (sensory-motor biofeed-
back device combined with timed voiding) versus a single inter-
vention (timed voiding alone) (Lewis 1990).
Specific intervention versus attention control
Monteiro 2014 compared 12 sessions of electrical stimulation of
the posterior tibialis nerve versus an attention control group. Par-
ticipants in the attention control group undertook a task involv-
ing 12 sessions of muscle-stretching training exercises of the lower
limb.
Diagnosis
Pre-stroke continence status
Only 11 trials, reporting 12 comparisons, included participants
who were continent prior to the stroke (Booth 2016; Chu 2011;
Guo 2014; Liu 2006; Liu 2013; Liu 2016a and Liu 2016b;
Monteiro 2014; Shin 2016a; Song 2013; Tibaek 2005; Tibaek
2017). Nine trials did not specify whether UI was subsequent
to the occurrence of stroke (Brittain 2000b; Chu 1997; Gelber
1997a; Gelber 1997b; Judge 1969; Lewis 1990; Zhang 1996;
Zhang 2002; Zhou 1999), although Lewis 1990 described partic-
ipants as having “post-stroke urinary urge incontinence.”
Further information on the continence status of participants prior
to stroke as defined by study authors can be found in Table 1.
Diagnostic criteria for urinary incontinence used by study
authors
Eight trials reporting nine comparisons gave diagnostic criteria for
incontinence (Brittain 2000b; Chu 2011; Guo 2014; Liu 2013;
Liu 2016a and Liu 2016b; Shin 2016a; Tibaek 2005; Tibaek
2017). Four trials specified a urological diagnosis: normal uro-
dynamic studies (Gelber 1997a); bladder hyper-reflexia (Gelber
1997b); urge incontinence (Lewis 1990); and urge, stress and
mixed stress/urge incontinence (Tibaek 2005). Judge 1969 re-
ported data for two groups of participants defined as mildly or
severely incontinent. Booth 2016 reported data on post-stroke
participants who reported incontinence at least once per week.
Liu 2006 reported data for three groups of participants, classified
according to the Barthel continence item: completely incontinent,
partially incontinent and independent. Liu 2006 and Monteiro
2014 reported data using the Barthel Index (bladder item). Chu
1997 included participants who had “urinary frequency or urinary
incontinence” but did not define urinary frequency further. One
trial reported participants met the “urological criteria for incon-
tinence” with no further details available in the translation (Song
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2013). Three trials did not include a urological diagnosis for par-
ticipants or group themby type or severity of incontinence (Zhang
1996; Zhang 2002; Zhou 1999).
For further information on the diagnostic criteria for incontinence
and the description of incontinence by study authors, see Table 1.
Diagnostic criteria for stroke used by study authors
Booth 2016, Tibaek 2005 and Tibaek 2017 diagnosed stroke ac-
cording to the World Health Organization’s clinical definition,
which includes confirmation by computed tomography (CT) or
magnetic resonance imaging (MRI) scan (WHO 1989). Simi-
larly, in Liu 2013 and Zhang 1996, a physician diagnosed stroke
and observed cerebral haemorrhage or infarction on cranial CT
or MRI. Tibaek 2005 included only first-ever ischaemic strokes.
All participants in the intervention arm of Tibaek 2017 had no
previous history of stroke. Song 2013 diagnosed stroke according
to 1995 National Meeting on Cerebrovascular Accidents diagnos-
tic criteria. Chu 2011 included participants diagnosed with first
or repeated episode of stroke according to the Fourth National
Conference on Cerebrovascular Disease. Monteiro 2014 assessed
participants with clinical and neuroimaging evaluations accord-
ing to established criteria from the Brazilian Cerebrovascular Dis-
ease Society. Eleven trials reporting 12 comparisons did not re-
port stroke diagnostic criteria (Chu 1997; Gelber 1997a; Gelber
1997b; Guo 2014; Judge 1969; Lewis 1990; Liu 2006; Liu 2016a
and Liu 2016b; Shin 2016a; Zhang 2002; Zhou 1999).
Participants in 10 trials reporting 11 comparisons included those
with cerebral infarction and haemorrhage (Booth 2016; Chu
2011; Guo 2014; Lewis 1990; Liu 2006; Liu 2013; Liu 2016a
and Liu 2016b; Song 2013; Zhang 1996; Zhou 1999). Two trials
included only participants with infarction (Tibaek 2005; Zhang
2002). In Zhang 2002, almost half of the participants had mul-
tiple cerebral infarctions. Judge 1969 included participants with
cerebrovascular accident or “multiple little strokes.” Two trials re-
ported that strokes were unilateral (Gelber 1997a; Gelber 1997b),
while one trial reported the stroke type as multi-focal infarction
(Chu 1997). Brittain 2000b included participants who self-re-
ported that they had had a stroke, subarachnoid haemorrhage or
transient ischaemic attack on a screening questionnaire.
Participants in Liu 2006 were 70.74 (SD 35.26) days post-stroke.
Three trials reporting four comparisons similarly recruited par-
ticipants between seven and 10 weeks post-stroke (Guo 2014;
Liu 2016a and Liu 2016b; Tibaek 2017). Zhou 1999 presented
findings for participants who were less than or more than three
months post-stroke. Shin 2016a reported participants were more
than three months post-stroke. Participants in three trials were
also less likely to be in the early rehabilitation phase, as they were
either occupying long-stay geriatric hospital beds or living at home
(Brittain 2000b; Judge 1969; Tibaek 2005). Booth 2016 recruited
people between zero andmore than five years after stroke.Of these,
12.2% (8 participants) were between zero and three months, and
30.6% (15 participants) were more than five years post-stroke. It
was difficult to identify the phase of stroke recovery for participants
in the other trials (Chu 1997; Gelber 1997a; Gelber 1997b; Lewis
1990; Liu 2013; Monteiro 2014; Zhang 1996; Zhang 2002).
Please see Table 2 for further information on the participants’
stroke history, stroke diagnostic information and stroke descrip-
tion.
Description of outcomes
Fifteen of the 20 trials clearly stated the primary outcome(s) of
interest in the trial. In six trials, this was the number of people with
UI (Brittain 2000b; Chu 1997; Chu 2011; Zhang 1996; Zhang
2002; Zhou 1999); in nine trials it was number of incontinent
episodes (Booth 2016; Gelber 1997a; Gelber 1997b; Judge 1969;
Lewis 1990; Liu 2006; Liu 2013; Tibaek 2005; Tibaek 2017).
Four trials had an additional primary outcome of urinary symp-
toms (Liu 2006; Liu 2013; Tibaek 2005; Tibaek 2017). Five trials
reporting six comparisons did not report a primary outcome (Guo
2014; Liu 2016a and Liu 2016b; Monteiro 2014; Shin 2016a;
Song 2013).
Please see Table 3 for further information on primary and sec-
ondary outcomes as described by study authors.
Excluded studies
We excluded 27 studies. Reasons for exclusion can be found in the
Characteristics of excluded studies but are summarised below.
• Four studies did not include a measure of continence (Cook
1998; Gross 1990; Humphreys 2014; Moon 2012).
• Five studies recruited participants in the acute phase of
stroke (Gong 2013; Thomas 2011; Wikander 1998; Yun 2007;
Zhu 2003); in addition to recruitment in the acute phase, Yun
2007 did not include a measure of continence.
• Six studies had stroke participants as a subgroup within
their overall participants but data for these participants were not
available or reported (Engberg 2002; Kuo 2007; McDowell
1999; NCT00213577; Sakakibara 2008; Stohrer 2013).
• Six studies did not include participants with stroke
(EUCTR2009-009216-53-PT; Gousse 2007; Kim 2003;
Madersbacher 2004; Madersbacher 2005; Vinsnes 2010).
• Three studies were terminated due to poor recruitment and
reported no data (Byles 2006; NCT01275261; Shin 2016c).
• We were unable to trace the author for further publications
or information for two studies (ISRCTN97151578; Smilskalne
2009).
• One study did not directly test a method of promoting
continence (Tekeoglu 1998).
Studies awaiting classification
We classified three studies as awaiting further assessment (
ACTRN12617000162314; ChiCTR-INR-16010239; Wang
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2014). Please see the Characteristics of studies awaiting
classification for details.
Ongoing studies
We identified two potentially eligible studies that are still ongoing
(NCT02568774; Shin 2016b). For more information, please see
the Characteristics of ongoing studies.
Risk of bias in included studies
The risk of bias judgements are summarised in Figure 2 and Figure
3, and described in the ’Risk of bias’ tables in the Characteristics
of included studies.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence generation
Nine trials reporting 10 comparisons were at low risk of bias for
random sequence generation (Booth 2016; Brittain 2000b; Chu
2011; Judge 1969; Liu 2016a and Liu 2016b; Shin 2016a; Song
2013; Tibaek 2005; Tibaek 2017). The remaining trials were at
unclear risk of bias.
Allocation (selection bias)
Three trials reporting four comparisons were at low risk of bias for
allocation concealment (Booth 2016; Judge 1969; Liu 2016a and
Liu 2016b). The remaining trials were at unclear risk of bias.
Blinding
Blinding of participants and personnel (performance bias)
Eight trials reporting nine comparisons were at low risk of bias
for blinding of participants or personnel, or both (Booth 2016;
Brittain 2000b; Judge 1969; Liu 2013; Liu 2016a and Liu 2016b;
Shin 2016a; Tibaek 2005; Tibaek 2017). The remaining trials
were at unclear risk of bias.
Blinding of outcome assessment (detection bias)
Six trials reporting seven comparisons were at low risk of bias for
blinding of outcome assessors (Booth 2016; Brittain 2000b; Liu
2013; Liu 2016a and Liu 2016b; Shin 2016a; Tibaek 2017). The
remaining trials were at unclear risk of bias.
Incomplete outcome data
Eight trials reporting nine comparisons were at low risk of bias
in relation to incomplete outcome data (Chu 2011; Judge 1969;
Liu 2006; Liu 2016a and Liu 2016b; Tibaek 2017; Zhang 1996;
Zhang 2002; Zhou 1999). Two trials were at high risk of bias
due to the large amount of attrition (Brittain 2000b), and lack
of prespecification of outcomes (Chu 1997). The remaining trials
were at unclear risk of bias.
Selective reporting
One study was at low risk of reporting bias as it had a published
protocol (Booth 2016). The remaining studies were at unclear risk
of bias as there were no study protocols available.
Other potential sources of bias
Eleven trials reporting 12 comparisonswere free fromother sources
of bias (Booth 2016; Brittain 2000b; Chu 2011; Guo 2014; Liu
2006; Liu 2013; Liu 2016a and Liu 2016b; Monteiro 2014; Shin
2016a; Tibaek 2005; Tibaek 2017). Two trials were at high risk
of other bias due to insufficient description of care received by the
comparison group and no assessment of participant characteristics
at baseline respectively (Chu 1997; Zhang 1996). The remaining
trials were at unclear risk of bias.
None of the trials reported power calculations, with the exception
of Tibaek 2017. Booth 2016 explicitly did not use a power calcu-
lation as this was a feasibility trial.
Effects of interventions
See: Summary of findings for themain comparisonBehavioural
interventions compared with usual care or no treatment for
treating urinary incontinence after stroke; Summary of findings 2
Specialised professional input interventions compared with usual
care or no treatment for treating urinary incontinence after stroke;
Summary of findings 3 Complementary therapy interventions
compared with usual care or no treatment for treating urinary
incontinence after stroke; Summary of findings 4 Physical
therapy interventions compared with usual care or no treatment
for treating urinary incontinence after stroke
For information relating to the quality of evidence for behavioural,
specialised professional input, complementary therapy and phys-
ical therapy interventions for the main comparison (interven-
tion versus no intervention/usual care), please refer to Summary
of findings for the main comparison, Summary of findings 2,
Summary of findings 3 and Summary of findings 4.
Data for prespecified outcomes were not available for each com-
parison except where reported below.
Intervention versus no intervention/usual care
(comparison 1)
Twelve trials reporting 13 comparisonswith 986 participants com-
pared an intervention to promote urinary continence against no
intervention or usual care (Brittain 2000b; Chu 1997; Gelber
1997a; Guo 2014; Liu 2006; Liu 2016a and Liu 2016b; Shin
2016a; Song 2013; Tibaek 2005; Tibaek 2017; Zhang 2002; Zhou
1999). The interventions included:
• behavioural interventions
◦ timed voiding versus void on request (usual care)
(Gelber 1997a)
◦ PFMT versus usual care (Shin 2016a; Tibaek 2005;
Tibaek 2017)
• specialised professional input interventions
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◦ care from a CNP versus usual care provided by a GP
(Brittain 2000b)
• complementary therapy interventions
◦ scalp acupuncture versus no scalp acupuncture (Chu
1997)
◦ eye acupuncture and scalp electroacupuncture versus
no acupuncture (Zhou 1999)
◦ knee and ankle acupuncture versus usual care (Zhang
2002)
◦ ginger-salt-partitioned moxibustion plus routine
acupuncture (multiple points) versus routine acupuncture (Liu
2006)
◦ electroacupuncture (multiple points) versus indwelling
catheter (Song 2013)
• physical therapy interventions
◦ TENS versus basic therapy (Guo 2014)
◦ TENS (two groups with different frequencies) versus
no treatment (Liu 2016a and Liu 2016b)
No data were available for the other interventions.
Primary outcomes
Number of participants continent after treatment
Six trials (including 766 people) reported the number of partic-
ipants who were continent after treatment (Brittain 2000b; Chu
2011; Liu 2006; Song 2013; Zhang 2002; Zhou 1999). Random-
effects models were used for the meta-analysis because of hetero-
geneity. The six trials included one specialised professional input
intervention (Brittain 2000b); and five complementary therapy
interventions (Chu 2011; Liu 2006; Song 2013; Zhang 2002;
Zhou 1999).
Specialised professional input interventions
Based onone trial ofmoderate-quality, specialist professional input
interventions in the form of structured assessment and manage-
ment probably made little or no difference to the number of peo-
ple continent at three months after treatment (RR 1.28, 95% CI
0.81 to 2.02; Brittain 2000b; Analysis 1.1.1; Summary of findings
2). At six months, the CNP intervention may have made little or
no difference to the number of people continent after treatment
(16/91 (17.5%) in the treatment group versus 8/55 (14.6%) in
the control group; RR 0.96, 95% CI 0.83 to 1.11; analysis not
shown; Brittain 2000b).
Complementary therapy interventions
Acupuncture and ginger-salt-partitioned moxibustion may have
increased the number of participants continent after treatment
(RR 2.82, 95% CI 1.57 to 5.07; 524 participants; low-quality
evidence; Chu 2011; Liu 2006; Song 2013; Zhang 2002; Zhou
1999; Analysis 1.1.2; Summary of findings 3). Studies were het-
erogeneous (I² = 78%) but favoured complementary therapy us-
ing the random-effects model. Visual inspection of the forest plot
suggested there was a larger effect size in Chu 2011 and Zhang
2002. It is difficult to suggest a possible explanation for this differ-
ence in treatment effect. However, Chu 2011 was the only trial to
use electroacupuncture rather than acupuncture and Zhang 2002
included younger participants, ranging from 42 to 62 years.
Number of incontinent episodes
Behavioural interventions
One trial measured the mean number of incontinent episodes
in 24 hours (Tibaek 2005). Behavioural interventions may have
made little or no difference to the number of incontinent episodes
(MD -1.00, 95% CI -2.74 to 0.74; 26 participants; P = 0.26; low-
quality evidence; Analysis 1.2.1; Summary of findings for themain
comparison). Tibaek 2017 reported the number of incontinent
episodes in 24 hours post-intervention was very small, with no
episodes in either the intervention or control group.
One trial compared timed voiding versus void on request, which
was interpreted as usual care (Gelber 1997a). The data reported
were too few even for tentative conclusions and we obtained no
further data from the investigators. This study was reported as
ongoing in a conference abstract.
Physical therapy interventions
TENS may have reduced the mean number of incontinent
episodes in 24 hours (MD -4.76, 95% CI -8.10 to -1.41; 142
participants; low-quality evidence; Guo 2014; Liu 2016a and Liu
2016b; Analysis 1.2.2; Summary of findings 4). There was a high
level of heterogeneity (I² = 94%) but findings favoured TENS
using the random-effects model. Visual inspection of the forest
plot suggested there was a larger effect size in Liu 2016a and Liu
2016b. A possible explanation for this difference in treatment ef-
fect may come from the number of days patients received TENS
(Guo 2014: mean number of days 48.7 (SD 10.5); Liu 2016a:
mean number of days 65.96 (SD 9.39); Liu 2016b: mean number
of days 71.01 (SD 14.86)).
Perception of improvement or cure
None of the trials reported perception of improvement or cure.
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Secondary outcomes
Urinary symptoms - overall urinary symptoms, mean
number of symptoms and leakage scores
Specialised professional input interventions
In Brittain 2000b, the CNP intervention may have slightly im-
proved the proportion cured of all four urinary symptoms (fre-
quency, nocturia, urgency and urinary incontinence) at three
months. The number of participants cured of all four urinary
symptoms was 24.7% in the treatment group versus 17.9% in the
control group (147 participants).
At six months, Brittain 2000b found a larger proportion of people
were cured of all four urinary symptoms in the treatment group
(41/89; 46.1%) compared with the control group (16/54; 29.6%)
(RR 1.55, 95% CI 0.97 to 2.48, Analysis 1.3.1).
There were no data suitable for analysis in relation to changes in
daytime and night-time leakage scores. However, the study teams
reported that theCNP interventionpossibly improved the daytime
severity of leakage at three months (P = 0.038).
Therewere nodata suitable for analysis in relation to changes in the
mean number of symptoms. However, the CNP intervention may
have slightly reduced the total number of symptoms experienced
at three months (P < 0.01). The intervention may have made little
or no difference to the total number of overall symptoms at six
months (P = 0.06; Brittain 2000b).
Urinary symptoms - frequency
Behavioural interventions
Data from two trials (48 participants) suggests that PFMT may
have slightly improved mean daytime voiding frequency (MD -
1.71, 95%CI -3.02 to -0.40; 48 participants; Tibaek 2005; Tibaek
2017; Analysis 1.4.1). There was no heterogeneity (I² = 0%).
Tibaek 2017 followed up participants for six months. We are un-
certain whether PFMT reduced voiding frequency: mean daytime
frequency was 6.8 (SD 3.2) in the treatment group and 8 (SD 3)
in the control group; mean night-time frequency was 2.1 (SD 1.7)
in the treatment group and 2.2 (SD 1.6) in the control group (19
participants).
Specialised professional input interventions
In Brittain 2000b, there was no evidence that the CNP interven-
tion made any difference to urinary frequency at three months
(98/120 (82%) in the treatment group versus 59/67 (88%) in the
control group; RR 0.93, 95% CI 0.82 to 1.05; 187 participants;
Analysis 1.5.1).
At six months, the CNP intervention may have made little or no
difference to urinary frequency (73/89 (82%) in the treatment
group versus 47/54 (87%) in the control group; RR 0.94, 95%
CI 0.82 to 1.09).
Complementary therapy interventions
One small trial suggested ginger-salt-partitioned moxibustion plus
routine acupuncture may have reduced mean daytime voiding
frequency (Liu 2006). Themean frequency of episodes was 7.03 in
the intervention group compared with 12.6 in the control group
(MD -5.57, 95% CI -7.00 to -4.14; 62 participants; Analysis
1.4.2).
There were no data suitable for analysis in the trial of scalp
acupuncture versus no scalp acupuncture (Chu 1997). After two
weeks and two courses of treatment, the investigators reported a
reduction in urinary frequency or incontinence of 90.3% in the
intervention group, with two people not regaining “normal urine,”
12 people partly regaining “normal urine” and 16 people regain-
ing “normal urine”. The authors reported a significant difference
between the experimental and control groups as “p (0.05~0.001).”
There were no reported results for the control group. The study
authors provided no further data.
Physical therapy interventions
Based on two trials, one reporting two comparisons, TENS may
have made no difference to daytime frequency (MD -2.83, 95%
CI -5.75 to 0.09; 142 participants; Guo 2014; Liu 2016a and Liu
2016b; Analysis 1.4.3). The trials were heterogeneous (I² = 93%).
Visual inspection of the forest plot suggested there was a larger
effect size in Liu 2016a and Liu 2016b. As we describe above in
relation to Analysis 1.2.2, a possible explanation for this difference
in treatment effect may come from the number of days patients
received TENS (Guo 2014: mean number of days 48.7 (SD 10.5)
days; Liu 2016a: mean number of days 65.96 (SD 9.39) days; Liu
2016b: mean number of days 71.01 (SD 14.86)).
Urinary symptoms - urgency
Specialised professional input interventions
In Brittain 2000b, there was no evidence that the CNP interven-
tion made a difference to urgency at three months. The number
of people reporting urgency was 95/121 (79%) in the treatment
group compared with 50/67 (75%) in the control group (RR 1.05,
95% CI 0.89 to 1.24; 188 participants; Analysis 1.6.1).
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At six months, the CNP intervention may have made little or no
difference to urinary urgency (65/91 (71.4%) in the treatment
group versus 40/54 (74%) in the control group; RR 0.96, 95%
CI 0.79 to 1.18).
Urinary symptoms - nocturia
Behavioural interventions
Two trials suggested PFMT may have made little or no differ-
ence in reducing nocturia (MD -0.38, 95% CI -1.06 to 0.29;
48 participants; P = 0.26, I² = 25%; Tibaek 2005; Tibaek 2017;
Analysis 1.7.1). This analysis used a random-effects model as it
was not readily possible to switch a subgroup analysis to a fixed-
effect model.
Specialised professional input interventions
One trial suggested the CNP intervention may have made little or
no difference to nocturia (Brittain 2000b). The number of people
reporting nocturia at three months was 102/119 (86%) in the
treatment group versus 60/67 (90%) in the control group (RR
0.96, 95% CI 0.86 to 1.07; Analysis 1.8.1).
At six months, the CNP intervention may also have made little
or no difference to nocturia (77/89 (87%) in the treatment group
versus 46/53 (87%) in the control group; RR 1.00, 95% CI 0.87
to 1.14).
Complementary therapy interventions
Two trials looking at ginger-salt-partitionedmoxibustion and elec-
troacupuncture respectively suggested that complementary ther-
apies may have made little or no difference in reducing nocturia
(MD -1.76, 95% CI -4.49 to 0.96; 256 participants; P = 0.20; Liu
2006; Song 2013; Analysis 1.7.2). The trials were heterogeneous
(I² = 98%). Visual inspection of the forest plot suggested there
was a larger effect size in Liu 2006. A possible explanation for this
difference in treatment effect could relate to the sample size: Liu
2006 had 62 participants included in the analysis, whereas Song
2013 had 194. Furthermore, the control group in Song 2013 had
an indwelling catheter inserted: this is usually only justified if there
are specific clinical reasons for insertion (for example when fluid
balance is critical) given the high risk of urinary tract infection
(ISWP 2016).
Physical therapy interventions
One trial suggested TENS may have improved nocturia (MD -
1.52, 95% CI -1.73 to -1.31; 61 participants; Analysis 1.7.3; Guo
2014).
Physical measures
Behavioural interventions
One trial suggested PFMT may have made little or no difference
to the mean function of the pelvic floor muscle (MD 0.10, 95%
CI -0.48 to 0.68; 23 participants; Tibaek 2005; Analysis 1.9.1).
One trial reported median pelvic floor muscle strength post-inter-
vention of 5 (IQR 4 to 6) in the treatment group versus 4 (IQR
4 to 5) in the control group; 30 participants; P = 0.07; Tibaek
2017).
One trial followed up participants for six months. We were uncer-
tain whether PFMT improved pelvic floor muscle strength (me-
dian 5 (IQR 4 to 6) in the treatment group versus 4 (IQR 3 to 5)
in the control group; 24 participants; P = 0.15; Tibaek 2017.
Health status and quality of life
Behavioural interventions
Therewas no evidence fromone trial that PFMTmade a difference
to themean total score of the SF-36 (MD -28.00, 95%CI -169.66
to 113.66; 24 participants; Tibaek 2005; Analysis 1.10).
One trial measured quality of life using the mean total score on
the IIQ (Tibaek 2005), and one trial used the Bristol Female
Lower Urinary Tract Symptoms Questionnaire (quality of life
items) (Shin 2016a). Data from these two trials provided no ev-
idence of a difference to quality of life (SMD -0.99, 95% CI -
2.83 to 0.86; 55 participants; low-quality evidence; Shin 2016a;
Tibaek 2005; Analysis 1.11.1; Summary of findings for the main
comparison). The trials were heterogeneous (I² = 90%). Visual
inspection of the forest plot suggested there was a larger effect size
in Shin 2016a . It is difficult to suggest a possible explanation for
this difference in treatment effect, however Shin 2016a included
participants around six months post-stroke whereas Tibaek 2005
included participants around 12 months post-stroke.
One trial measured health status using the SF-36 pre- and post-
intervention (Tibaek 2017). There were no significant differences
reported and data were unsuitable for pooling.
One trial followed up participants for six months (Tibaek 2005).
We were uncertain whether PFMT improved health status. Total
scores on the SF-36 were 550 (SD 170) in the treatment group
(12 participants) and 596 (SD 124) in the control group (12
participants) (P = 0.6; Tibaek 2005). Higher scores on the SF-36
indicate a more favourable health status. There was no evidence
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that PFMT changed quality of life at six months: scores on the
IIQ were 43 (SD 76) in the treatment group (12 participants) and
47 (SD 50) in the control group (11 participants) (P = 0.45).
One trial followed up participants for six months (Tibaek 2017).
We were uncertain whether PFMT improved health status mea-
sured by the SF-36 (30 participants).
Functional ability
Physical therapy interventions
Twocomparators of one three-arm trial (81 participants)measured
function using the Barthel Index (Liu 2016a and Liu 2016b).
TENS (Liu 2016a: 20Hz; Liu 2016b: 75Hz frequencies) probably
improved overall functional ability (MD 8.97, 95% CI 1.27 to
16.68; moderate-quality evidence; Analysis 1.12).
Participant satisfaction
Specialised professional input interventions
One trial measured participant satisfaction with the service
(Brittain 2000b). The CNP intervention may have improved
participant satisfaction at three months (dissatisfaction: 13/109
(12%) in the treatment group versus 17/45 (38%) in the control
group; RR 0.32, 95% CI 0.17 to 0.59; Analysis 1.13).
Adverse events
In Song 2013, 45/136 (33%) of participants in the intervention
group reported bruising on arms and torso with full recovery; 17/
136 (13%) had abdominal pain postacupuncture with resolution
after warm compress. There were no other adverse effects.
Three trials reporting four comparisons reported no adverse events
(Guo 2014; Liu 2016a and Liu 2016b; Tibaek 2017). Four trials
reported no information on adverse events (Brittain 2000b;Gelber
1997a; Shin 2016a; Tibaek 2005). In four trials, it was unclear if
any adverse events occurred (Chu 1997; Liu 2006; Zhang 2002;
Zhou 1999).
Intervention versus placebo (comparison 2)
Three trials with 137 participants compared an intervention to
promote urinary continence against placebo (Booth 2016; Judge
1969; Liu 2013). One reported on a physical therapy intervention
(Booth 2016), one reported on pharmacotherapy in the form of
oestrogen (Judge 1969), and the other reported on complementary
therapy (Liu 2013).
Primary outcomes
Number of participants continent after treatment
Physical therapy interventions
Data from one trial provided no evidence that transcutaneous pos-
terior nerve stimulation made a difference to the number of partic-
ipants continent at 12 weeks (Booth 2016). The trial reported that
3/27 (11.1%) participants in the treatment group were continent
compared with 4/27 (14.8%) in the sham intervention group (RR
0.75, 95% CI 0.19 to 3.04; Analysis 2.1).
Number of incontinent episodes
Physical therapy interventions
Data from one trial provided no evidence that TPTNS made a
difference to the number of incontinence episodes (MD -1.10,
95%CI -3.99 to 1.79; 39 participants; Booth 2016; Analysis 2.2).
One trial followed up participants for six months (Booth 2016). It
is uncertain whether TPTNS reduced the number of UI episodes
at follow-up (odds ratio (OR) 1.43, 95% CI 0.38 to 5.32).
Pharmacotherapy interventions
One small cross-over trial compared an intervention designed to
promote urinary continence (oestrogen) against placebo in a long-
term care setting in 12 women with a history of stroke (Judge
1969). The trial reported results separately for participants with
mild or severe incontinence and in view of the significant hetero-
geneity between the two groups, we used a random-effects model.
There was no evidence that oestrogen therapymade a difference to
themean number of incontinent episodes per week inmild incon-
tinence (paired samples for mild incontinence, MD -1.71, 95%
CI -3.51 to 0.09; Analysis 2.3.1) or severe incontinence (paired
samples, MD -6.40, 95% CI -9.47 to -3.33; Analysis 2.3.2).
Perception of improvement or cure
Physical therapy interventions
One trial reported that a single Patient Perception of Bladder Con-
dition question suggested improvement in the TPTNS group at
the 26-week time point (OR 0.04, 95% CI 0.004 to 0.41; Booth
2016). There was no evidence of a difference in perceived bladder
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condition at six weeks (OR 2.33, 95% CI 0.63 to 8.65) and 12
weeks (OR 1.22, 95% CI 0.29 to 5.17).
Secondary outcomes
Urinary symptoms
Complementary therapy interventions
One trial (71 participants) found that acupuncture may have re-
duced the frequency of urination and UI (Liu 2013). The fre-
quency of urination and UI were lower after electroacupuncture
than before treatment (urination: P = 0.03; UI P = 0.01); these
differences were not observed in the control group (urination: P
= 0.71; UI: P = 0.68). The frequency of urination and UI were
lower in the electroacupuncture group than in the control group
immediately after intervention (urination: P = 0.03; UI: P = 0.03).
These differences remained after at least fivemonths (intervention:
urination: P = 0.04; UI: P = 0.01; control: urination P = 0.03; UI:
P = 0.01); with differences lasting up to at least five months (P <
0.05 for all outcomes). Formal comparisons were not conducted
as suitable data were not received from study authors.
Physical therapy interventions
Booth 2016 reported no evidence of a difference in urgency be-
tween groups at weeks 12 and 26 (week 12: OR 0.49, 95% CI
0.13 to 1.87; week 26: OR 0.68, 95% CI 0.18 to 2.59). The trial
also reported no evidence of a difference in frequency between
groups at weeks 12 and 26 (week 12: OR 0.45, 95% CI 0.11 to
1.84; week 26: OR 0.41, 95% CI 0.12 to 1.44). There was no
evidence of an effect for nocturia at weeks 12 or 26 (week 12: OR
1.07, 95% CI 0.22 to 5.05; week 26: OR 0.73, 95% CI 0.16 to
3.32).
Physical measures
Complementary therapy interventions
One trial (66 participants) measured detrusor overactivity using
maximum cystometric capacity and bladder compliance and de-
trusor leak point pressure (Liu 2013).However, datawere reported
as change from baseline in the intervention arm only and was not
comparative. Therefore, the data were unusable.
Health status and quality of life
Physical therapy interventions
Data from one trial provided no evidence that transcutaneous pos-
terior nerve stimulation made a difference to quality of life mea-
sured with the International Consultation on Incontinence Ques-
tionnaire - Lower Urinary Tract Symptoms Quality of Life ques-
tionnaire (ICIQLUTSqol) (MD 3.90, 95% CI -4.25 to 12.05; 30
participants; Booth 2016; Analysis 2.4).
One trial reported quality of life using the EQ-5D-5L (Booth
2016). The EQ-5D-5L means were calculated as the average of
the utilities at each time point of the trial. The calculation was
done separately for each trial arm. Every participant’s EQ-5D-
5L response was translated into a utility score using the UK tariff
and the mean utility was calculated across participants for each
trial arm. Themaximum possible score for a utility was 1 for a per-
fect health response in each of the five dimensions, the minimum
was a negative number around -0.4 as reported in the UK tariff.
There was no evidence of a difference between groups; both groups
improved over time with a mean improvement of around 23%.
Baseline scores were 0.435 (SD 0.331) in the treatment group and
0.500 (SD 0.273) in the control group.
Functional ability
None of the trials reported functional ability.
Participant satisfaction
None of the trials reported participant satisfaction.
Adverse events
In Booth 2016, one (3.7%) participant in the intervention group
and one (3.7%) participant in the sham group had residual urine
volume of more than 150 mL at the six-week bladder scan. One
participant (group unclear) hadminor skin irritation and one par-
ticipant (group unclear) reported ankle cramping. One trial re-
ported no adverse events (Judge 1969). One trial reported no in-
formation on adverse events (Liu 2013).
Specific intervention versus another intervention
(comparison 3)
Two trials with 76 participants compared a specific intervention
with another intervention (Gelber 1997b; Zhang 1996).
Zhang 1996 reported on complementary therapy. Gelber 1997b
compared a behavioural intervention (timed voiding) with a phar-
macotherapy intervention (oxybutynin). However, the data were
too few for useful analysis and no further data could be obtained
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from the investigators. This study was reported as ongoing in a
conference abstract.
Primary outcomes
Number of participants continent after treatment
Complementary therapy interventions
One trial compared different acupuncture needles and depth of
needle insertion to assess the effect on incontinence in 57 par-
ticipants (Zhang 1996). The elongated needle was inserted to a
depth of five Cun (Chinese inches; one of which is equivalent to
the width of a thumb) and compared with a filiform needle in-
serted to a depth of 1.5 Cun. The study authors reported that, af-
ter four courses of treatment, 25 (78.1%) participants in the elon-
gated needle group were ’cured’ (no incontinent episodes) versus
10 (40%) in the filiform needle group.
Number of incontinent episodes
None of the trials reported the number of incontinent episodes.
Perception of improvement or cure
None of the trials reported perception of improvement or cure.
Secondary outcomes
Urinary symptoms
None of the trials reported urinary symptoms.
Physical measures
None of the trials reported physical measures.
Health status and quality of life
None of the trials reported health status or quality of life.
Functional ability
None of the trials reported functional ability.
Participant satisfaction
None of the trials reported participant satisfaction.
Adverse events
None of the trials reported information on adverse events.
Combined intervention versus single intervention
(comparison 4)
One trial (23 participants) compared a combined intervention
(sensory motor biofeedback plus timed prompted voiding) de-
signed to promote urinary continence against a single intervention
(timed voiding) (Lewis 1990).
Primary outcomes
Number of participants continent after treatment
One trial compared a combined intervention (sensory motor
biofeedback plus timed prompted voiding) designed to promote
urinary continence against a single intervention (timed voiding)
(Lewis 1990). There was no evidence that the combined interven-
tion made a difference to the number of participants continent (1/
11 (9%) in the combined intervention group versus 2/12 (16.7%)
in the control group; RR 0.55, 95% CI 0.06 to 5.21; Analysis
4.1.1).
Number of incontinent episodes
The combined intervention tested (sensory motor biofeedback
plus timed prompted voiding versus timed prompted voiding)
may have made a difference to the mean number of incontinent
episodes; the control group reported fewer episodes of inconti-
nence (3.5) compared with 5.7 in the combined group (MD 2.20,
95% CI 0.12 to 4.28; Lewis 1990; Analysis 4.2.1).
Perception of improvement or cure
The trial did not report perception of improvement or cure.
Secondary outcomes
Urinary symptoms
The trial did not report urinary symptoms.
Physical measures
The trial did not report physical measures.
Health status and quality of life
The trial did not report health status or quality of life.
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Functional ability
The trial did not report functional ability.
Participant satisfaction
The trial did not report participant satisfaction.
Adverse events
The trial did not report any information on adverse events.
Specific intervention versus attention control
(comparison 5)
One trial with 24 participants compared a specific intervention
(TPTNS) with attention control (stretching exercises) (Monteiro
2014).
Primary outcomes
Number of participants continent after treatment
Data from one trial (24 participants) found no evidence that
TPTNSmade a difference to the number of participants continent
after treatment compared to an attention control group undertak-
ing stretching exercises (Monteiro 2014). The trial reported 4/12
(33.3%) participants in the intervention group were continent on
completion of the 45-day intervention period compared with 3/
12 (25%) participants in the attention control group (RR 1.33,
95% CI 0.38 to 4.72; Analysis 5.1.1).
One trial (24 participants) followed up participants for 12 months
(Monteiro 2014). We were uncertain whether electrical stimula-
tion of the posterior tibialis nerve improved urge incontinence:
three (25%) participants in the electrical stimulation group re-
ported no urge incontinence compared with four (33%) partici-
pants in the placebo group (P = 0.67).
Number of incontinent episodes
The trial did not report number of incontinent episodes.
Perception of improvement or cure
The trial did not report perception of improvement or cure post-
intervention (Monteiro 2014).
One study followed up participants for 12 months (Monteiro
2014). Electrical stimulation of the posterior tibial nervemay have
made a difference to subjective improvement in symptoms (12
(100%)participants in the electrical stimulation group versus three
(25%) participants in the placebo group; P = 0.001).
Secondary outcomes
Urinary symptoms
Post-intervention, one study found seven (58%) participants re-
ported urinary urgency in the treatment group compared with
10 (83%) participants in the attention control group (P = 0.18;
Monteiro 2014). Five (42%) participants in the treatment group
had nocturia post-intervention compared with nine (75%) partic-
ipants in the attention control group (P = 0.09).
One study (24 participants) followed up participants for 12
months (Monteiro 2014). We are uncertain whether electrical
stimulation of the posterior tibialis nerve improved urinary ur-
gency: six (50%) participants in the electrical stimulation group
reported urgency compared with nine (75%) participants in the
placebo group (P = 0.20). Electrical stimulation of the posterior
tibial nerve may have made a difference to nocturia at 12 months:
one (8%) participant in the TPTNS group had nocturia compared
with six (50%) participants in the attention control group (P =
0.02).
Physical measures
The trial did not report physical measures.
Health status and quality of life
The trial did not report health status or quality of life.
Functional ability
The trial did not report functional ability.
Participant satisfaction
The trial did not report participant satisfaction.
Adverse events
The trial did not report any information on adverse events.
Subgroup analysis
It was not possible to conduct planned subgroup analyses of the
effect of urological diagnosis or time from stroke onset to recruit-
ment to the trial due to lack of available data.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Specialised professional input interventions compared with usual care or no treatment for treating urinary incontinence after stroke
Patient or population: people with stroke and urinary incont inence
Settings: hospital, clinic or home
Intervention: specialised professional input
Comparison: no treatment/ usual care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Intervention
Number of participants
continent after treat-
ment
- three months
354 per 1000 453 per 1000
(287 to 715)
RR 1.28
(0.81 to 2.02)
121 part icipants (1) ⊕⊕⊕©
Moderatea
-
Number of incontinent
episodes
- - - - - Not reported
Perception of improve-
ment or cure
- - - - - Not reported
Health status and qual-
ity of life
- - - - - Not reported
Functional ability - - - - - Not reported
Adverse events - - - - - Not reported.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; RR: risk rat io.
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GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aDowngraded by one level for study design (allocat ion concealment unclear).
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Complementary therapy interventions compared with usual care or no treatment for treating urinary incontinence after stroke
Patient or population: people with stroke and urinary incont inence
Settings: hospital, clinic or home
Intervention: complementary therapy
Comparison: no treatment/ usual care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Intervention
Number of participants
continent after treat-
ment
Study population RR 2.82
(1.57 to 5.07)
524 part icipants (5) ⊕⊕©©
Lowa
-
193 per 1000 544 per 1000
(303 to 978)
Number of incontinent
episodes
- - - - - Not reported
Perception of improve-
ment or cure
- - - - - Not reported
Health status and qual-
ity of life
- - - - - Not reported
Functional ability - - - - - Not reported
Adverse events - - - - See comment Song 2013: 45/ 136
(33%) in the interven-
t ion group had bruises
on arms and torso
with full recovery; 17/
136 (13%) had abdom-
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inal pain post-acupunc-
ture with resolut ion af -
ter warm compress; no
other adverse ef fects
noted
Chu 1997; Liu 2006;
Zhang 2002; Zhou
1999: unclear
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; RR: risk rat io.
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aDowngraded one level for study design (random sequence generat ion unclear in 3/ 5 trials in the meta-analysis; allocat ion
concealment unclear in 5/ 5 trials), and by one level for imprecision: 3/ 5 studies fewer than 100 part icipants.
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Physical therapy interventions compared with usual care or no treatment for treating urinary incontinence after stroke
Patient or population: people with stroke and urinary incont inence
Settings: hospital, clinic or home
Intervention: physical therapy
Comparison: no treatment/ usual care
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Intervention
Number of participants
continent after treat-
ment
- - - - - Not reported
Number of incontinent
episodes
The mean number of
incont inent episodes
ranged across control
groups f rom 0.74 to 3.
51
The mean number of
incont inent episodes in
the intervent ion groups
was 1.61 to 4.69
MD -4.76
(-8.10 to -1.41)
142 part icipants (2
studies (1 3-arm study)
)
⊕⊕©©
Lowa
-
Perception of improve-
ment or cure
- - - - - Not reported
Health status and qual-
ity of life
- - - - - Not reported
Functional abil-
ity: mean Barthel score
(continuous variables)
The mean Barthel score
was 52.5 in the control
groups
The mean Barthel score
in the intervent ion
groups was 57.9 to 65.
8
MD 8.97
(1.27 to 16.68)
81 part icipants (1 × 3-
arm study)
⊕⊕⊕©
Moderateb
-
Adverse events - - - - - Not reported
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* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; MD: mean dif ference.
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aDowngraded one level for study design (random sequence generat ion unclear in 1/ 2 trials in the meta-analysis; allocat ion
concealment unclear in 1/ 2 trials), and one level for imprecision: 2/ 2 studies fewer than 100 part icipants.
bDowngraded one level for imprecision: fewer than 100 part icipants.
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D I S C U S S I O N
Summary of main results
As there are many reasons why UI interventions might work dif-
ferently in people with stroke compared with the general popula-
tion, the review aimed to consider the effects (benefits and harms)
of all interventions designed to treat UI after stroke in adults. Ex-
perimental studies tested a wide range of intervention types. In-
terventions were also variable within intervention categories, for
example types of acupuncture (traditional or electroacupuncture)
and areas of the body used for needle insertion.
Behavioural interventions
Five trials assessed behavioural interventions such as timed voiding
andPFMT.All trials had very small sample sizes (fewer than50par-
ticipants) and the limited published data for the main outcome of
number of people continent after treatment did not permit meta-
analysis. There was evidence from one trial that behavioural inter-
ventions may reduce the mean number of incontinent episodes in
24 hours (Tibaek 2005), while two trials suggest that PFMT may
slightly improve mean daytime voiding frequency (Tibaek 2005;
Tibaek 2017). However, behavioural interventions may make lit-
tle or no difference to health status and quality of life (Shin 2016a;
Tibaek 2005; low-quality evidence), urinary symptoms (night-
time voiding frequency) (Tibaek 2005; Tibaek 2017), or physical
measures (pelvic floor muscle function) compared with usual care
(Tibaek 2005).
Specialised professional input interventions
There is no evidence that CNP intervention made a difference
to urinary frequency or urgency at three months. The interven-
tion may have improved participant satisfaction with the service at
three months and the number of people continent at six months
compared with usual care (Brittain 2000b; moderate-quality ev-
idence). The proportion of participants for whom results were
available at six months was quite low (63%) and some of the data
could not be analysed.
Complementary therapy interventions
Complementary therapies using acupuncture, electroacupuncture
and ginger-salt-partitioned moxibustion may increase the number
of participants continent after treatment when compared with
usual care (Chu 2011; Liu 2006; Zhang 2002; Zhou 1999; low-
quality evidence), or placebo (Liu 2013), and may reduce mean
daytime voiding frequency compared with usual care (Liu 2006).
However, there is no evidence of a difference in night-time voiding
frequency (Liu 2006; Song 2013).
These trials reportedminimal methodological detail and it is likely
they were of poor quality. It is also not clear whether, and how,
these interventions are transferable to the health services of other
countries. In addition, the newer studies reported the use of elec-
troacupuncture while the earlier studies used traditional acupunc-
ture. There was wide variation within the acupuncture interven-
tions in terms of the target acupoint.
Pharmacotherapy interventions
In the small cross-over trial testing oral oestrogen against placebo,
there were fewer incontinent episodes per week during oestrogen
treatment inwomenwith severe incontinence (Judge 1969).How-
ever, it is only known that the participants had a history of stroke.
The high mean age of the participants in the trial, the presence
of confusion and lack of mobility, combined with the setting in
which the trial took place (two geriatric hospitals) suggested that
continence problemsmay have been secondary to other conditions
as well as stroke. For this reason, it is problematic to generalise
these results to women after stroke. Furthermore, the dose pre-
scribed was not in line with current recommendations. Hormone
replacement therapy is now widely considered to be contraindi-
cated in women who have had, or are at risk of, stroke and there is
evidence that oestrogens increase incontinence in postmenopausal
women (Hendrix 2005).
There is a lack of evidence on whether the many other forms of
intervention shown to have some value in the general population
would also be beneficial to people after stroke. In particular, there
are no usable results from trials testing the use of bladder relaxants
such as anticholinergics, programmes of timed voiding or bladder
training, physical aids, environmental or lifestyle interventions.
Physical therapy interventions
Compared to usual care, physical therapy using transcutaneous
electrical nerve stimulation may reduce the mean number of in-
continent episodes in 24 hours (Guo 2014; Liu 2016a and Liu
2016b; low-quality evidence), reduce nocturia (Guo 2014), and
probably improves functional ability (Liu 2016a and Liu 2016b;
moderate-quality evidence). However, physical therapy interven-
tions may make little or no difference to daytime voiding fre-
quency (Guo 2014; Liu 2016a and Liu 2016b).
Compared to placebo, physical therapy makes little or no differ-
ence to health status, quality of life or the number of incontinent
episodes (Booth 2016). Booth 2016 was a feasibility trial with 54
participants and was not designed to assess effectiveness.
Overall completeness and applicability of
evidence
The major point of interest in the included studies was the mix
of categories of intervention, including physical, behavioural and
complementary therapies, drugs and professional input interven-
tions such as using trained personnel and specificmethods of man-
aging care. However, within categories it was often not possible
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to combine studies due to data not being in the appropriate for-
mat. Sensitivity analyses were not conducted as too few studies
reported outcomes of interest for each comparison type. It was not
possible to conduct sensitivity analysis by low or high risk of bias
as all except one of the studies were classified at unclear risk of
bias for the domain of selective outcome reporting. The majority
of studies had unclear risk of bias on the remainder of the risk of
bias domains.
Quality of the evidence
Overall, the evidence was moderate or low-quality (see Summary
of findings for the main comparison; Summary of findings 2;
Summary of findings 3; Summary of findings 4). The most com-
mon reasons for downgrading the evidence were:
• risk of selection bias due to inadequate reporting of random
sequence generation and allocation concealment; and
• imprecision due to small sample size.
Only three trials had a sample of 100 participants ormore (Brittain
2000b; Chu 2011; Song 2013); eight had fewer than 50 partic-
ipants (Gelber 1997a; Gelber 1997b; Judge 1969; Lewis 1990;
Monteiro 2014; Shin 2016a; Tibaek 2005; Tibaek 2017). Small
sample sizes meant CIs were wide, making it difficult to ascertain
if there were any clinically or statistically important differences
between groups. The evidence may also be subject to small-study
bias. Only four trials (reporting five comparisons) had adequate
allocation concealment (Booth 2016; Brittain 2000b; Judge 1969;
Liu 2016a and Liu 2016b); many were limited by poor report-
ing. For most, it was impossible to judge the extent to which they
might have been prone to bias. The review was also limited by the
lack of full data for five trials (Brittain 2000b; Chu 1997; Gelber
1997a; Gelber 1997b; Lewis 1990).
Potential biases in the review process
The method of dividing the sample size across comparisons with
more than one treatment arm may not correct unit-of-analysis
errors (Liu 2016a and Liu 2016b). Although this technique is in
line with that described in the Cochrane Handbook for Systematic
Reviews of Interventions, using a different method (combining data
from multiple active treatment arms into a single arm) may have
had an impact on Analysis 1.4.3 and Analysis 1.12.1, although
the overall quantity of data available was small.
The original protocol for this review specified inclusion criteria
for participants as having had a stroke in the previous 12 months.
However, this definition proved unworkable as most of the trials
did not report time since stroke. Time since stroke was less than
three months in five studies reporting six comparisons (Chu 2011;
Guo 2014; Liu 2016a and Liu 2016b; Song 2013; Tibaek 2017).
One study reported the time since stroke as approximately six
months (Shin 2016a). Booth 2016 had a variable time from stroke
to recruitment (12.2% (six) were recruited within three months
of stroke; 20.4% (10) were between three and six months post-
stroke; 12.2% (six) were between six and 12 months post-stroke
and 55.1% (27) were recruited more than 12months post-stroke).
There was also a lack of clarity about whether UI was subsequent
to stroke; only 12 trials specified that urinary continence problems
were subsequent to stroke.
Very limited datawere available for longer-term follow-up after the
end of the intervention period. Where this was available, follow-
up periods varied from three to 12 months. Six trials reported
outcomes beyond the post-intervention period: Chu 2011, Guo
2014, Liu 2016a and Liu 2016b, Song 2013, Tibaek 2017 and
Booth 2016 reported outcomes at three and six months. Liu
2013 did not report three-month data in a suitable format for
inclusion in the review. Tibaek 2005, Tibaek 2017 and Brittain
2000b reported follow-up at six months (in the latter, follow-up
data were missing for 85 (37%) participants), and Monteiro 2014
at 12 months.
Duration of the intervention was also variable. Duration of PFMT
versus usual care ranged from a six-week intervention consisting of
three 50-minute sessions perweek (Shin 2016a), to an intervention
lasting 12 weeks (Tibaek 2005; Tibaek 2017). The duration of
complementary therapy interventions ranged fromoneweek (Chu
1997; Zhang 2002) to four weeks (Song 2013; Zhou 1999).
The extent to which the results can be generalised to people with
continence problems solely as the result of stroke was unclear.
Furthermore, the information regarding the severity of inconti-
nence at the time of recruitment was unclear across the trials. It
is very likely there were differences in participants’ severity of in-
continence based on examining the trials’ inclusion criteria for ’in-
continence’. Inclusion criteria detail for incontinence varied and
ranged from participants with ’urinary incontinence’ (Guo 2014);
’episodes occurring at least once a week’ (Booth 2016); leakage
several times a month or stress incontinence most of the time, fre-
quency every half-hour/hour, nocturia three or more times a night
and urgency most of the time (Brittain 2000b).
Agreements and disagreements with other
studies or reviews
To our knowledge, there are no other comparable studies or re-
views delivering interventions designed to improve continence af-
ter stroke in the rehabilitation phase of stroke recovery.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is very little evidence from stroke-specific studies to guide
practice. The lack of trials testing the same category of interven-
tion means that recommendations for practice are based on the
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results of a few, usually small trials, providing generally low-quality
evidence overall.
Implications for research
Evidence suggesting that beneficial outcomes may be achieved
by structuring the management of care for people with urinary
continence problems following a stroke points to the need for
larger trials (Brittain 2000b). Given the variety of problems that
can hinder the maintenance of continence after stroke, the use of
individualised assessment and goal setting to tailor interventions to
the neurological and functional problems of the individual would
seem to be especially worthy of consideration.
Trials of complementary therapies, namely acupuncture alone
(Chu 1997; Chu 2011; Liu 2006; Liu 2013; Song 2013; Zhang
1996; Zhang 2002; Zhou 1999), or combined with ginger-salt-
partitioned moxibustion (Liu 2006), suggest these interventions
may be worth investigating further with more rigorous study de-
sign.
Transcutaneous electrical nerve stimulation may reduce the num-
ber of incontinent episodes andwarrants further investigationwith
the stroke population, particularly given its simplicity and ease of
use (Booth 2016; Guo 2014; Liu 2016a and Liu 2016b).
Methods of managing continuing urinary incontinence (UI) such
as behavioural interventions (e.g. bladder training, prompted void-
ing and pelvic floor muscle training) require testing with the stroke
population, both inhospital and in the community post-discharge.
There is a need for more appropriately powered, multi-centre tri-
als of interventions to provide robust evidence to improve UI af-
ter stroke. These trials may be simple (e.g. pharmacological inter-
ventions) but many will be complex interventions exploring be-
havioural interventions and more technical interventions, such as
acupuncture or electrical stimulation.
Further research should use standardised definitions and classifi-
cation systems to record details of the type and severity of stroke,
as well as the type and severity of UI. Pre-stroke continence status,
time since stroke and stroke recurrence should also be recorded,
with clear inclusion criteria for continence status. Exclusion cri-
teria should be given for comorbidities and clinical indicators of
underlying urogenital or systemic conditions such as infection.
Specific details of structured assessment and intervention proto-
cols need to be given, with standardisation of treatment, measures
of between groups contamination or differences, and tailoring of
intervention to the early or later phases of rehabilitation. Outcome
measures of UI and of urinary symptoms should be standardised
with attention to their validity and reliability and the blinding of
outcome assessment. The measurement of changes in health-re-
lated quality of life would be valuable. The time periods for review
should be standardised for the early and later phases of rehabili-
tation. Lastly, sample size calculations and secure randomisation
at either the cluster or individual participant level should be used
appropriately.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Booth 2016
Methods Design: randomised controlled feasibility trial
Study dates: May 2014 to August 2016
Setting: UK, Scotland; intervention and sham intervention delivered in participants’
homes
Participants 54 men and women
Number and % women: intervention 15 (55.6%); control 15 (55.6%)
Age (mean): intervention 67.1 (SD 10.9) years; control 66.9 (SD 11.4) years
Description of stroke and UI:
Ischaemic stroke: intervention 21 (87.5%); control 22 (88.0%)
Haemorrhagic stroke: intervention 3 (12.5%); control 2 (8.0%)
Inclusion criteria: men or women aged ≥ 18 years with diagnosis of stroke based on
the WHO criteria (WHO 1989) and stroke-related UI of at least once weekly. Onset of
stroke≥ 4 weeks previously and discharged from hospital to own home within previous
6 months. Physically, cognitively and communicatively able and willing to learn to apply
TPTNS or has carer able and willing to learn. Informed consent provided (by carer proxy
if required)
Exclusion criteria: pre-existing UI prior to stroke, current UTI or voiding dysfunction
requiring intermittent/indwelling catheterisation, cardiac pacemaker in situ, concurrent
neurological diagnosis including dementia and multiple sclerosis, diabetic neuropathy,
reduced/absent sensation at electrode placement sites, postvoid residual urine volume >
150 mL, unable to provide informed consent
Interventions Intervention group: 27 participants. TPTNS intervention programme self-delivered or
delivered by the stroke survivor’s carer in the stroke survivor’s home following individual
education to enable this to take place. The full TPTNS treatment programme comprised
12 stimulation sessions of 30 minutes’ duration, delivered twice weekly over 6 weeks.
Two surface electrodes applied to non-hemiparetic ankle, where appropriate, or right an-
kle where no hemiparesis exists: first electrode placed 6 cm cephalad to medial malleolus
and 2 cm behind tibia. Second electrode placed 10 cm cephalad to first. Electrical stim-
ulator cathode lead connected to distal electrode and anode lead to proximal. Electrical
stimulator preprogrammed to safely deliver 30 minutes of continuous stimulation with
a pulse frequency of 10 Hz and pulse width 200 µs. Intensity of the current depends on
the stroke survivor’s perception threshold and individual comfort and is self-adjusted at
each session, but will normally range between 15 mA and 40 mA
Control group: 27 participants. Sham stimulation group received a similar programme
of 12 × 30-minute sessions twice weekly for 6 weeks. However, surface electrodes were
positioned on the lateral malleolar area of ankle, not the medial aspect, to avoid the
posterior tibial nerve. Stimulation intensity increased until sensation was reported, then
turned down to 4 mA for the 30-minute session, ensuring that despite avoiding the
posterior tibial nerve, there was no therapeutic stimulation provided
All participants, regardless of group, were informed that they may experience little or no
sensation during the treatment session
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Booth 2016 (Continued)
Outcomes Outcomes measured at baseline, 6, 12 and 26 weeks.
Primary outcome: reported episodes and severity of episodes of UI (ICIQ-UI-SF)
Secondary outcomes: number of adverse events, urinary symptoms (AUA Symptom
Index), functional ability (Barthel Index), quality of life (EQ-5D-5L; ICIQLUTSqol)
Funding source Stroke Association
Declarations of interest among primary re-
searchers
None reported
Notes No baseline imbalance
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation stratified by sex; block
length used was random to help maintain
allocation concealment
Allocation concealment (selection bias) Low risk Randomisation delivered using ’SealedEn-
velope.com’ using an allocation list derived
by Lancashire CTU staff. Trial staff re-
cruited participants. For consented partic-
ipants, after having checked eligibility, re-
cruiting staff entered participant’s informa-
tion (sex) into ’SealedEnvelope.com’ (on-
line) andwere informedby email of the par-
ticipant’s allocation (to TPTNS or sham)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants blind as neither intervention
nor sham group knew their allocation.
TPTNS education provided by study re-
search associates who could not be blinded
to group allocation as procedure for each
group was different. Outcome measure-
ment was unlikely to be influenced by lack
of blinding of personnel
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome measures were self-reported us-
ing postal questionnaires.Where telephone
completion was necessary, this was done by
a researcher blind to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Of the 54 participants recruited, 44 (81.
5%) completed the 6-week outcomes, 40
(74.1%) completed the 12-week outcomes
and 39 (72.2%) completed the 26-week
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Booth 2016 (Continued)
outcomes. Reasons for missing data pro-
vided
Selective reporting (reporting bias) Low risk Protocol available. Some prespecified sec-
ondary outcomes (e.g. Barthel Index,Mod-
ified Rankin Scale, postvoid residual urine
volume) not reported in final report but
supplied by study author
Other bias Low risk Quote: “The groups were similar in their
baseline characteristics indicating the suc-
cess of randomisation.”
Brittain 2000b
Methods Design: RCT
Study dates: August 1997 to June 2000
Setting: UK, at home
Participants 232 male (61%) and female (39%) adult stroke survivors with UI. Gender by group
allocation not reported
Age: 40-96 years, mean 70 years
Inclusion criteria: stroke diagnosed by self-report questionnaire as stroke, subarachnoid
haemorrhage or transient ischaemic attack. Self-reported clinically significant urinary
symptoms, including leakage of urine, stress incontinence, frequency, nocturia or urgency
Exclusion criteria: pregnancy, physical causes of urinary tract dysfunction (prolapse,
urethral stricture, prostatic obstruction, pelvic mass or malignancy in past 5 years), active
treatment for incontinence in past 6 months, neurogenic retention, raised postresidual
volumes, glycosuria or haematuria
Interventions Intervention group: 152 participants. CNP assessment and treatment. CNP received 3
months’ training and used formatted assessment and guidelines for treatment, which
could include habit retraining, pelvic floor awareness, dietary advice, provision of conti-
nence garments and GP referral for treatment of atrophic vaginitis, candidiasis or con-
stipation. Intervention comprised 6 contacts and 5 treatment visits at weeks 1, 2, 4, 6
and 8. Week 1: history + physical examination; week 2: diagnostic visit + development
of management plan; weeks 4 and 6: review, adapt + reinforce management plan; week
8: reassessment
Control group: 80participants.Usual care provided byGPand referral to existing services
for the management of continence
Outcomes Outcomes measured at 3 and 6 months. Nurse assessment and self-report by participant:
frequency, nocturia, urgency, UI, daytime leakage, night-time leakage
At 3 months: all of the above and satisfaction with service
Funding source NHS Cardiovascular Disease and Stroke National Research and Development Pro-
gramme
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Brittain 2000b (Continued)
Declarations of interest among primary re-
searchers
None reported
Notes Subsample of the Medical Research Council Incontinence Study
1:1 randomisation.
No baseline differences in age and gender between groups
Proportions for which data reported: 82% at 3 months, 63% at 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “For each batch of subjects, nine
individual lists of allocations, (one for each
of the interviewers who will be recruiting
subjects) were generated using the SAS pro-
cedure PROC PLAN. Random permuted
blocks of 10 … (5 GP, 5 CNP) … These
lists were stored as confidential paper lists,
and in a read and write protectedMicrosoft
ACCESS database.”
Allocation concealment (selection bias) Unclear risk Quote: “Randomisation envelopes were
prepared by clerical staff on the study team.
Envelopes had a trial, batch number, list
number and envelope number printed on
the front. Stroke randomization envelopes
were white.”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk No blinding but outcome unlikely to be
influenced by lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk No blinding but outcome unlikely to be
influenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
High risk Large amount of attrition: 190/232 (81.
9%) remaining at 3 months; 147/232 (63.
4%) remaining at 6 months. Reasons given
but not by group
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk No significant differences in age and gender
between groups.
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Chu 1997
Methods Design: RCT
Study dates: 1992-1994
Setting: China
Participants 32 (53%) male and 28 (47%) female adult ischaemic stroke survivors with UI/frequency
Participants described as having multifocal cerebral infarction
Age: men 50-71 years, women 45-61 years
Inclusion criteria: not reported
Exclusion criteria: not reported
Interventions Intervention group: 30 participants. Scalp acupuncture using the “bai hui” channel. Nee-
dle in situ for 1-2 days in hot weather, and 3-7 days in cold weather. Needle manipulated
every 4 hours. Treatment period: 1-2 weeks
Control group: 30 participants. Usual care. No scalp acupuncture treatment
Outcomes Prespecified outcomes and timing not reported. 2-week follow-up reported as interven-
tion group totally regaining “normal urine.”
Control group: no results given.
Funding source Not reported
Declarations of interest among primary re-
searchers
None reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomised into 2 groups; no description
given.
Allocation concealment (selection bias) Unclear risk Insufficient information available to permit
judgement.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcomes not stated prior to treatment.
Selective reporting (reporting bias) Unclear risk No protocol available.
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Chu 1997 (Continued)
Other bias High risk Authors “selected 60 patients” from 120
treated during 1992-1994. Women ap-
peared younger than men but it was not
stated whether this was statistically signif-
icant. No other participant characteristics
reported other than gender and age; unable
to assess between-group differences prior to
intervention
Group 2: “No scalp acupuncture treat-
ment;” unclear what this group received
Chu 2011
Methods Design: RCT
Study dates: hospital inpatients recruited between May 2007 and October 2010
Setting: China, setting unclear
Participants 111 men and women
Number and % women: intervention 33 (60%), control 29 (53%)
Age (mean): Intervention 66.4 (SD 9.32) years, control 64.5 (SD 8.63) years
Time since stroke (days): intervention 35.1 (SD 25.6), control 35.4 (SD 23.9)
Stroke type:
Intervention group: cerebral haemorrhage 16 (28.6%); cerebral infarction 40 (71.4%);
anepia, loss of speech 6 (10.7%); vascular dementia 5 (8.9%)
Control group: cerebral haemorrhage 14 (25.4%); cerebral infarction 41 (74.5%);
anepia, loss of speech 5 (9.1%); vascular dementia 4 (7.3%)
Inclusion criteria: first or repeated episode of stroke, according to the Fourth National
Conference on cerebrovascular disease in 1995; in line with the above described diagnos-
tic criteria; duration ≤ 6 months; age > 40 years; no incontinence prior to this episode;
consenting informed
Exclusion criteria: not reported
Interventions Intervention group: 56 participants. Intervention given in addition to control measures
(described below). Electroacupuncture at Shengshu points (bilaterally) and Huiyang
points (bilateral), with the needle being rotated every 10 minutes. Treatment given at 1
Hz, and titrated to participant’s tolerance of electroacupuncture. Given daily once, 30
minutes’ duration. Total of 4 weeks, with 1 day break each week. Caution is paid to
fainting (therapy immediately stopped with removal of needles and allowing participant
to lie flat with head lowered; hot water or sugar water given). Severe cases given emergency
treatment, such as: haematoma, local bleeding. Heat compresses given to help reduce
scarring
Control group: 55 participants. Treated according to clinical condition with standard
medical therapy, such as lowering blood pressure with calcium channel antagonists, an-
giotensin-converting enzyme inhibitors, angiotensin 2 receptor antagonists etc.), im-
proving circulation with 500 mg bolus and continuous venous drip after, functional
improving therapy such as scalp acupuncture, body acupuncture (acupuncture with ro-
tation of 100 rounds per min), done daily for total of 4 weeks
48Interventions for treating urinary incontinence after stroke in adults (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chu 2011 (Continued)
Outcomes Outcomes measured pre- and post-intervention (4 weeks): UI grading score; clinical
symptoms score (frequency, urgency, incontinence); urinary infection
Funding source Not reported
Declarations of interest among primary re-
searchers
None reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised numbers in envelopes drawn
by participants and then checked against a
random number chart for allocation
Allocation concealment (selection bias) Unclear risk Sealed envelopes, which then are checked
against random number chart
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No description of blinding.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description of blinding.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcomes reported for all participants ran-
domised.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk None detected
Gelber 1997a
Methods Design: multi-arm RCT (2-arms)
Study dates: not reported
Setting: not reported
Participants 18 adults
Number and % women: not reported
Age: not reported
Unilateral stroke survivors with UI and normal urodynamic studies
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Gelber 1997a (Continued)
Interventions Intervention group: 10 people allocated to void on request
Intervention group: 8 people allocated to timed voiding
No further details given
Outcomes Number of incontinence episodes per day, averaged for each month of treatment for 1
year. No numerical results reported
Funding source Not reported
Declarations of interest among primary re-
searchers
None reported
Notes Gelber 1997 comprised of 4 arms (Gelber 1997a (2 arms) and Gelber 1997b (2 arms)
) with 37 participants in total. Randomisation was separate and in 2 different groups;
therefore we reported it as 2 × 2-armed trials
This trial was reported as ongoing in a conference abstract.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient evidence about sequence gen-
eration process.
Allocation concealment (selection bias) Unclear risk Method of concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition not reported.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
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Gelber 1997b
Methods Design: multi-arm RCT (2-arms)
Study dates: not reported
Setting: not reported
Participants 19 adults
Number and % women: not reported
Age: not reported
Unilateral stroke survivors with UI and bladder hyper-reflexia
Interventions Intervention group: 10 participants allocated to timed voiding
Intervention group: 9 participants allocated to oxybutynin
No further details given
Outcomes Number of incontinence episodes per day, averaged for each month of treatment for 1
year. No numerical results reported
Funding source Not reported
Declarations of interest among primary re-
searchers
None reported
Notes Gelber 1997 comprises of 4 arms (Gelber 1997a (2 arms) and Gelber 1997b (2 arms)
) with 37 participants in total. Randomisation was separate and in 2 different groups;
therefore we reported it as 2 × 2-armed trials
This trial was reported as ongoing in a conference abstract.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient evidence about the sequence
generation process.
Allocation concealment (selection bias) Unclear risk Method of concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition not reported.
Selective reporting (reporting bias) Unclear risk No protocol available.
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Gelber 1997b (Continued)
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias exists
Guo 2014
Methods Design: RCT
Study dates: not reported; participants were hospitalised between January 2010 and
January 2011
Setting: China, hospital neurology department
Participants 61 men and women
Number and % women: 19 (31.2%)
Age: intervention 68.1 (SD 7.1) years, control 65.1 (SD 9.8) years
Description of stroke and UI:
Ischaemic stroke: intervention 24 participants, control 23 participants
Haemorrhagic stroke: intervention 8 participants, control 6 participants
Time since stroke: intervention 48.7 (SD 10.5) days, control 53.1 (SD 18.2) days
Inclusion criteria: people with post-stroke UI, stable, co-operative and could effectively
communicate (to accomplish therapy), and could finish the survey on urination and pre-
and post-treatment
Exclusion criteria: people with urinary retention, various reasons for UI in the past
(Parkinson’s disease, spinal cord disease, dementia, urinary tract tumours, urolithiasis,
unhealed UTIs or history of urinary tract surgery), severe cognitive function disorders
(Mini-Mental State Examination 14-22 points), unable to communicate effectively, con-
current serious organic diseases, needed massive fluid infusion or usage of drugs that
affected urination and unable to provide accurate survey information or to complete the
treatment period
Interventions Intervention group: 32 participants. TENS (model TENS-21; Homer Ion Laboratory
Company Ltd, Tokyo, Japan) for 30minutes once per day for 60 days with pulse duration
70µS and frequency 75Hz in formof unidirectional square wave.Maximum therapeutic
current 16 mA (1 k). According to the nerve innervation, the electrodes’ pads were
placed as follows: the positive electrode (39 cm²) was on the second lumbar spinous
process and 2 negative electrodes (30 cm²) were on the inside of the middle and lower
third of the junction between the posterior superior iliac spine and the ischia node.
Reusable silicone gel electrodes were used in the study and a small amount of water was
placed in the electrodes to make good electrical contact
Control group: 29 participants. Basic therapy.
Outcomes Measured pre- and post-intervention (60 days)
OABSS (self-report), Barthel Index, urodynamic examination (daily micturitions, noc-
turia, urgency, UI)
Funding source Not reported
Declarations of interest among primary re-
searchers
Author reported no conflict of interests.
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Guo 2014 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants randomly divided into 2
groups.
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment of low or high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment of low or high risk
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Outcome data in Table 2 completed for
all participants. For Table 3 and Table 4
it was not clear if any participants missing
from analyses. For Table 3, the Barthel In-
dex score was > 50 points for 21 (65.63%)
participants in the treatment group but for
only 10 (34.48%) participants in the con-
trol group (Table 2); there were no further
details on other participants. For Table 4,
there were no details of numbers of partic-
ipants in analyses in either group or text
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Low risk None detected from the information pro-
vided
Outcome data in Table 2 complete for all
participants (32 and 29)
For Table 3 and Table 4 it was not clear if
any participants missing from analyses. For
Table 3 the Barthel Index score was > 50
points for 21 (65.63%) participants in the
treatment group but for only 10 (34.48%)
participants in the control group (Table 2);
there were no further details on other par-
ticipants. For Table 4, there were no details
of numbers of participants in analyses in
either group or text
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Judge 1969
Methods Design: double-blind cross-over trial
Study dates: not reported
Setting: UK, Scotland, long-stay geriatric hospitals
Participants 12 women (stroke subgroup)
Age: mean 82 years, range 66-92 years
12/18 women with diagnosis of cerebrovascular accident or “multiple little strokes”, 7
with mild incontinence (mean 12.3 episodes per week), and 5 with severe incontinence
(mean 41.1 episodes per week)
Inclusion criteria: none stated
Exclusion criteria: faecal impaction, urinary infection
Interventions Intervention group: quinestradol 0.25 mg 4 times per day for 1 month
Control group: placebo with a washout period of 1 month
Outcomes Baseline number of incontinent episodes per week and number of incontinent episodes
at week 5
Funding source William R. Warner and Co supplied the Pentovis for the trial
Declarations of interest among primary re-
searchers
None reported
Notes Participants in intervention group (defined as ’mildly incontinent’) and control group
(defined as ’severely incontinent’) were from 2 different hospitals
Most participants were mentally confused, 8 participants were classified as ’chairfast’ and
4 participants were classified as ’bedfast.’
20 participants recruited with data reported for 18/20 participants, 1 participant died,
1 withdrew. The stroke subgroup consisted of 12 participants
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A set of random numbers was
used.”
Allocation concealment (selection bias) Low risk Quote: “The hospital Pharmacist was pro-
vided with active product and placebo la-
belled only ’Capsules X’ and ’Capsules Y’
along with a sealed key for emergency use.
A set of random numbers was used in Phar-
macy and one month’s supply of capsules
issued.”
Comment: pharmacy controlled randomi-
sation.
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Judge 1969 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “A strict double-blind crossover
technique was used.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data available for all but 2 participants. 1
participant died in the early stages of the
trial, 1 became too confused to take the
capsules following a second cerebrovascular
accident
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk Most participants were mentally confused
Lewis 1990
Methods Design: RCT
Study dates: not reported
Setting: not reported
Participants 23 people with stroke
Number and % women: not reported
Age: not reported
23 adults with post-stroke urinary urge incontinence.
5 (22%) haemorrhagic stroke, 18 (78%) ischaemic stroke.
Interventions Intervention group: 11participants. Sensory-motor biofeedback device (Uristop) + timed
prompted voiding. The Uristop device powered by 1 penlight battery was worn around
the waist. It had a heritor probe which detected the onset of urination and delivered a
single electrical twitch stimulus pulse via surface electrodes to the perineum
Control group: 12 participants. Timed prompted voiding; no description reported
Treatment time 2 weeks.
Outcomes Outcome measured at 2 weeks’ post-intervention
Incontinence, number of incontinence episodes
Funding source Not reported
Declarations of interest among primary re-
searchers
None reported
Notes Continence defined as 0 incontinent episodes in the last 2 days of study
Trial reported in a conference abstract.
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Lewis 1990 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient evidence about the sequence
generation process.
Allocation concealment (selection bias) Unclear risk Method of concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to permit
judgement.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition not reported.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk Insufficient information to assess whether
an important risk of bias existed
Liu 2006
Methods Design: RCT
Study dates: October 2004 to September 2006
Setting: China, inpatient
Participants 35 men (47%) and 40 women (53%) stroke survivors with UI.
Number of women in each arm: intervention 18 (46.1%), control 17 (47.2%)
Age (mean): intervention 64.7 (SD 7.48) years, control 62.3 (SD 8.41) years
Cerebral infarction: intervention 30 (76,9%), control 30 (83.3%)
Cerebral haemorrhage: intervention 9 (23.01%), control 6 (16.7%)
Inclusion criteria: cerebral infarction or haemorrhage, time between stroke onset and
admission to hospital < 6 months, continent of urine prestroke, presence of UI, urgent
or frequent micturition when condition stabilised after stroke, micturition problems
affected quality of life, conscious and able to communicate, normal recognition, aged
40-75 years
Exclusion criteria: comorbidities involving the heart, kidney or other important or-
gans; prestroke chronic urinary retention and UI, unable to communicate, long-standing
chronic UTI
Interventions Intervention group: 39 participants. Ginger-salt-partitioned moxibustion at Sheque (CV
8) and routine acupuncture (e.g. Tsusanli, Yinlingquan). Treatments delivered 5 times
per week for 3 weeks
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Liu 2006 (Continued)
Control group: 36 participants. Routine acupuncture
Outcomes Outcome measures reported before and after treatment at 3 weeks
Mean number of urination times each day, mean number of times requesting toileting
at night, number of participants with incontinence at 72 hours, urgent UI during day
Funding source None reported in translation.
Declarations of interest among primary re-
searchers
None reported in translation.
Notes Study reported in Chinese and translated into English.
No baseline differences in age, gender, type of stroke, stroke course, frequency symptoms
and grade of UI between the groups
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Abstract stated “randomly divided;” no fur-
ther information provided
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not described
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk Appeared complete; data analysis excluded
participants with catheters. Attrition rea-
sons reported for both groups
Selective reporting (reporting bias) Unclear risk Protocol not available.
Other bias Low risk None detected
Liu 2013
Methods Design: randomised, double-blind, placebo-controlled
Study dates: June 2008 to June 2012
Setting: China, outpatient, Department of Neurology
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Liu 2013 (Continued)
Participants 71 men and women
Number and % women: intervention 12 (36.4%), control 13 (39.4%)
Age (mean): intervention 39 (SD 12) years, control 37 (SD 11) years
Description of stroke and UI: all participants had a history of cerebral infarction or
cerebral haemorrhage but the sites of the lesion were different in the 2 groups and the
numbers of participants with lesions at specific sites were small. Acute stroke diagnosed
by a physician and cerebral haemorrhage or infarction observed on cranial CT or MRI
Infarction: intervention 13 (39.4%), control 17 (51.5%)
Haemorrhagic: intervention 20 (60.6%), control 16 (48.5%)
Detrusor overactivity assessed using voiding diaries and urodynamic testing according
to the AUA/SUFA guidelines using a urodynamic testing system (Laborie Medical Tech-
nologies, Beijing, China)
Inclusion criteria: aged 20-50 years, acute stroke diagnosed by a physician and cerebral
haemorrhage or infarction observed on cranial CT orMRI; stable condition, and mobile
in a wheelchair or undergoing rehabilitation, for ≥ 6 months; no indwelling urinary
catheter
Exclusion criteria: previous acupuncture treatment; pregnant or planning pregnancy;
implanted pacemaker; implanted neurostimulator; cardiac arrhythmia; epilepsy; severe
heart, brain, lung or othermajor organ disease; acid-base or electrolyte imbalance; history
of severe kidney disease, hydronephrosis, bladder stoma, sphincterotomy or severe exag-
geration of autonomic nervous system reflexes; UTI; cognitive disorder and acupuncture
syncope
Interventions Intervention group: 35 participants. Electroacupuncture. Considering the differences
among participants, individualised acupuncture administered in combination with tra-
ditional Chinese acupuncture methods. According to modern acupuncture methods,
points Baliao (including bilateral Shangliao (BL31), bilateral Ciliao (BL32), bilateral
Zhongliao (BL33), and bilateral Xialiao (BL34)) and Huiyang, which are closely asso-
ciated with the sacral micturition centre, were selected. Participants placed in lateral or
prone position. Entire procedure performed under sterile conditions. Target skin ster-
ilised using 75%ethanol and stainless steel 30-gauge acupuncture needles (Guizhou Andi
Medicated Instruments, Guizhou, China) inserted medially and obliquely into points
Baliao and Huiyang. Needles inserted to a depth of 3.5-4.0 cm at points Baliao, at the
first to fourth dorsal sacral foramina, and to a depth of 3.5-5.0 cm at point Huiyang. De
qi (a sensation of numbness and distension at the needling site) was achieved by manual
stimulation. Electroacupuncture (30-40 Hz, continuous wave) performed at points Xi-
aliao and Huiyang. Electroacupuncture then performed at the remaining points using
the HM6805-2 Acupoint Pulse Therapy Instrument (20-30 mA; Sichuan Hengming
Technology Development, Sichuan, China). Stimulation intensity adjusted to achieve
rhythmic muscle contractions in anus and perineal region and be tolerable to the par-
ticipants. After completion of acupuncture, the acupuncturist left and the participant
rested on bed. Electroacupuncture performed daily for 10 consecutive days, and needles
inserted for 20 minutes each time. Only 1 set of interventions administered
Control group: 36 participants. Sham electroacupuncture, as recommended by WHO.
Points Baliao were used, which are closely associated with the sacral micturition centre.
Needles attached to 1 cm diameter rings, which were attached to participant using
surgical tape. Positions of the participant and acupuncturist, procedures, duration of
stimulation, and timing of interventions identical to procedures in electroacupuncture
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group. Needles attached to positions 1 cm lateral to the acupoints. Sham acupuncture
needles did not pierce the skin. The electrical wire used for sham electroacupuncture was
broken so it could not conduct electricity. After the intervention, the acupuncturist left
and the participant rested on the bed. The needles were left in position for 20 minutes
each time. Sham electroacupuncture was performed daily for 10 consecutive days
Outcomes Outcomesmeasured at the beginning and end of treatment and at the 3month follow-up:
mean maximum cystometric capacity, bladder compliance, detrusor leak point pressure,
frequency of urination and UI
Funding source Study supported by the Postdoctoral Foundation of Heilongjiang Province, No.
LRB2008-384
Declarations of interest among primary re-
searchers
Authors declared no conflicts of interests.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The subjects were randomly as-
signed.”
Allocation concealment (selection bias) Unclear risk Quote: “To ensure that the proportions of
patients with severe urinary frequency and
incontinence were similar in both groups,
these parameters were taken into consider-
ation during group assignment. The group
of each subjectwas recorded, and the record
was placed in an opaque envelope and sent
to the investigator. The investigator opened
the envelope and informed the acupunc-
turist of the group assignment.”
Comment: group selection appeared to
take place after randomisation. Unclear if
envelopes were sequentially numbered and
sealed
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “The subjects and evaluators were
blinded to the group assignment.”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The subjects and evaluators were
blinded to the group assignment.”
59Interventions for treating urinary incontinence after stroke in adults (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Liu 2013 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Numbers of participants included in analy-
sis not reported. 2/35 dropped out of inter-
vention group, 3/36 dropped out of con-
trol group with reasons provided
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk None detected.
Liu 2016a
Methods Design: multi-arm RCT (3-arm)
Study dates: participants recruited during hospitalisation between July 2011 and January
2013
Setting: China, inpatients or outpatients (group A and B), outpatient (group C)
Participants 81 men and women
Number and % women: group A 5 (18.52%), group B 8 (29.63%), group C 10 (37.
04%)
Age (mean): group A 66.30 (10.84) years, group B 63.75 (8.92) years, group C 67.91
(7.39) years
Description of stroke and UI:
Cerebral haemorrhage: group A 6 (22.22%), group B 9 (33.33), group C 7 (25.93)
Cerebral infarction: group A 21 (77.78), group B 18 (66.67), group C 20 (74.07)
Time since stroke (mean): group A 65.96 (SD 9.39) days, group B 71.01 (SD 14.86)
days, group C 67.82 (SD 11.58) days
Inclusion criteria: people with UI after stroke who were stable, co-operative and could
effectively communicate to participate in therapy; and people who could complete the
survey on urination both before and after treatment
Exclusion criteria: people with urinary retention, history of UI for various reasons
(Parkinson’s disease, spinal cord disease, dementia, urinary tract tumours, urolithias,
unhealed UTIs or history of urinary tract surgery); needed significant fluid infusions
or drugs that affected urination; concurrent serious organic diseases; severe cognitive
functioning disorders (Mini-MentaI State Examination score < 22 points); unable to
communicate effectively; unable to provide accurate survey information or to complete
the treatment period
Interventions Groups A and B (interventions): 27 participants in each group. TENS (model EN-
Stim 4; ENRAF-NONIUS Company Ltd. Rotterdam, the Netherlands) for 30 minutes
once daily for 90 days in hospital (as inpatients or outpatients). The TENS device used
a 4-channel stimulator with fully independent channels and 4 sets of moist pads for
rubber electrodes (6 × 8 cm). This process makes it possible to treat major muscle groups
simultaneously or to perform bilateral treatments simultaneously. The TENS currents
were biphasic square waves with pulse durations of 150 µseconds and pulse frequencies of
20 Hz (group A) or 75 Hz (group B). Underwent OABSS, Barthel Index, urodynamics
and voiding diary assessments on the first day and at 90 days
Group C (control): 27 participants. OABSS, Barthel Index, urodynamics and voiding
diary assessments on the first day and at 90 days
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Outcomes Outcomes measured at day 1 (baseline) and day 90 (last day of the intervention)
OABSS, Barthel Index, voiding diary, urodynamic values
Funding source No funding grants or equipment provided from any source. No financial benefits to
authors
Declarations of interest among primary re-
searchers
Authors declared no conflicts of interest.
Notes Liu 2016a and Liu 2016b are two arms of a multi-arm RCT reporting on two separate
comparisons
Liu 2016a referred to group A (20 Hz) and group C (control)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was computer
generated.”
Allocation concealment (selection bias) Low risk Quote: “the allocation was centrally gener-
ated and concealed.”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “both the patients and therapists
were blinded to the treatment groups”
(group A and group C)
Comment: neither participants nor thera-
pists blinded to allocation to no treatment/
treatment but unlikely outcome influenced
by lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “An independent physician who
did not participate in the clinical manage-
ment and who was kept blinded to treat-
ment allocation conducted the assessment.
”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants dropped out of study.
Complete outcome data.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk None detected.
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Methods Design: multi-arm RCT (3-arm)
Study dates: participants recruited during hospitalisation between July 2011 and January
2013
Setting: China, inpatients or outpatients (group A and B), outpatient (group C)
Participants 81 men and women
Number and % women: group A 5 (18.52%), group B 8 (29.63%), group C 10 (37.
04%)
Age (mean): group A 66.30 (10.84) years, group B 63.75 (8.92) years, group C 67.91
(7.39) years
Description of stroke and UI:
Cerebral haemorrhage: group A 6 (22.22%), group B 9 (33.33), group C 7 (25.93)
Cerebral infarction: group A 21 (77.78), group B 18 (66.67), group C 20 (74.07)
Time since stroke (mean): group A 65.96 (SD 9.39) days, group B 71.01 (SD 14.86)
days, group C 67.82 (SD 11.58) days
Inclusion criteria: people with UI after stroke who were stable, co-operative and could
effectively communicate to participate in therapy; and people who could complete the
survey on urination both before and after treatment
Exclusion criteria: people with urinary retention, history of UI for various reasons
(Parkinson’s disease, spinal cord disease, dementia, urinary tract tumours, urolithias,
unhealed UTIs or history of urinary tract surgery); needed significant fluid infusions
or drugs that affected urination; concurrent serious organic diseases; severe cognitive
functioning disorders (Mini-MentaI State Examination score < 22 points); unable to
communicate effectively; unable to provide accurate survey information or to complete
the treatment period
Interventions Groups A and B (interventions): 27 participants. TENS (model EN-Stim 4; ENRAF-
NONIUS Company Ltd. Rotterdam, the Netherlands) for 30 minutes once daily for
90 days in hospital (as inpatients or outpatients). The TENS device used a 4-channel
stimulator with fully independent channels and 4 sets of moist pads for rubber electrodes
(6 × 8 cm). This process makes it possible to treat major muscle groups simultaneously or
to perform bilateral treatments simultaneously. The TENS currents were biphasic square
waves with pulse durations of 150 µseconds and pulse frequencies of 20 Hz (group A)
or 75 Hz (group B). Underwent OABSS, Barthel Index, urodynamics and voiding diary
assessments on the first day and at 90 days
Group C (control): 27 participants. OABSS, Barthel Index, urodynamics and voiding
diary assessments on the first day and at 90 days
Outcomes Outcomes measured at day 1 (baseline) and day 90 (last day of the intervention)
OABSS, Barthel Index, voiding diary, urodynamic values
Funding source No funding grants or equipment provided from any source. No financial benefits to
authors
Declarations of interest among primary re-
searchers
Authors declared no conflicts of interest.
Notes Liu 2016a and Liu 2016b are two arms of a multi-arm RCT reporting on two separate
comparisons
Liu 2016b referred to group B (75 Hz) and group C (control)
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization was computer
generated.”
Allocation concealment (selection bias) Low risk Quote: “the allocation was centrally gener-
ated and concealed.”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “both the patients and therapists
were blinded to the treatment groups”
(group A and group B)
Comment: neither participants nor thera-
pists blinded to allocation to no treatment/
treatment but unlikely outcome influenced
by lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “An independent physician who
did not participate in the clinical manage-
ment and who was kept blinded to treat-
ment allocation conducted the assessment.
”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants dropped out of study.
Complete outcome data.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk None detected.
Monteiro 2014
Methods Design: RCT
Study dates: February 2007 to June 2008
Setting: Brazil, stroke outpatient
Participants 24 men
Age (mean): intervention 65.1 (SD 3.6) years, control 56.1 (SD 10.9) years
Description of stroke and UI:
Right hemisphere stroke: intervention 7 (58.3%), control 8 (67%)
Left hemisphere stroke: intervention 7 (58.3%), control 5 (42%)
Inclusion criteria: men who had stroke aged ≥ 18 years, stroke occurring 6 months to 3
years before recruitment
Exclusion criteria: men who had implanted cardiac pacemaker, UTI, bladder cancer, pre-
existing UI before stroke, surgery in urogenital region
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Interventions Intervention group: 12 participants. Electrical stimulation with the Duplex-961 system
(Quark, Piracicaba, São Paulo, Brazil). With the participant seated, surface electrodes
placed on skin with conductive gel and secured with adhesive tape. A negative electrode
placed on medial malleolus and positive electrode placed 10 cm above the negative elec-
trode, also on the medial side. Rhythmic flexion of second toe during stimulation deter-
mined the correct position of the negative electrode. Intensity level set below threshold
that caused motor contraction because participant should have been comfortable and
with no pain during procedure. Electrical stimulation of the posterior tibialis nerve per-
formed for 30 minutes twice weekly over 12 sessions (45 days), with frequency of 10 Hz
and pulse width of 200 mseconds in continuous mode
Control group: 12 participants. 12 stretching sessions of lower limbs. 3muscle-stretching
training sessions conducted to instruct participants how to perform each of these 3 series
of 30-second stretching exercises at home. Participants did not receive other types of
physical therapy or any specific behavioural guidelines for overactive bladder during 12-
month follow-up
Outcomes Outcomes measured before treatment, after treatment (12 sessions, 45 days) and 12-
month follow-up
3-day voiding diary (urgency, urge incontinence, nocturia, nocturnal enuresis, increased
daytime frequency
Barthel index
At 12 months: self-report of symptom improvement
Funding source Not reported
Declarations of interest among primary re-
searchers
None stated
Notes Authors reported significant difference in age between groups, intervention group older
than control group. No other baseline differences
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “To ensure random allocation, all
participants were numbered sequentially
from 1 to 24 and divided into 2 groups of
12 patients assigned to the treatment group
(electrical stimulation of the posterior tib-
ialis nerve) and 12 to the control group.”
Comment: insufficient information to per-
mit judgement.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment.
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Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 1 participant in the control group
dropped out due to death
Numbers given for each group in the find-
ings table given as 36 per group. However,
only 24 participants randomised
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk Baseline imbalance in age: intervention
group older than control group (65.1 (SD
3.6) years vs 56.1 (SD10.9) years). Authors
suggested that if the groups had been equal,
the effect of the intervention might have
been demonstrated even more clearly
Shin 2016a
Methods Design: randomised, single-blind controlled study
Study dates: not reported
Setting: Korea, participants recruited from a rehabilitation centre
Participants 35 women
Age (mean): intervention 62.08 (SD 3.32) years, control 62.92 (SD 4.93) years
Description of stroke and UI:
Paretic side: intervention: left 6 (37.5%), right 10 (62.5%); control: left 7 (46.7%), right
8 (53.3%)
Time since stroke: intervention 6.17 (SD 1.53) months, control 5.17 (SD 2.08) months
Inclusion criteria: > 3 months post-stroke, had UI after stroke, experienced normal
vaginal delivery, could understand and follow simple verbal instructions (Korean version
of Mini-Mental State Examination score) and no other treatments administered for UI
Exclusion criteria: UTI, symptoms of vaginal prolapse, chronic respiratory diseases, psy-
chiatric diseases, and other neurological diseases
Interventions Intervention: 16 participants. General rehabilitation + education of UI and the functions
of the PFMs + PFMT. General rehabilitation training consisting of gait training and
stretching not affecting the PFMs for 50 minutes, 3 times per week for 6 weeks. In
addition: participants received PFMT for 50 minutes, 3 times per week for 6 weeks.
PFMT involved the education of UI and the functions of PFMs, recognition training,
training in a range of respiratory conditions and PFMs resistance training. Education
of UI and the functions of the PFMs carried out by a trained physiotherapist with
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specific knowledge on the basic anatomy and PFM function. To improve recognition of
the PFMs, a sensory ball with protruding projections was used on the surface provided
individually
Control: 15 participants. General rehabilitation + education of UI and the functions of
the PFMs
Outcomes Outcomes were measured pre- and post-intervention (6 weeks).
Electromyography, Bristol Female Urinary Symptoms Questionnaire
Funding source This research received no specific grant from any funding agency in the public, com-
mercial or not-for-profit sectors
Declarations of interest among primary re-
searchers
Authors declared no conflicts of interest.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk To minimise selection bias, participants
were assigned randomly to either a PFMT
group or control group using Random Al-
location Software
Allocation concealment (selection bias) Unclear risk Not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Outcomes not likely to be influenced by
lack of blinding.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk 2 trained raters tested maximum vaginal
squeeze pressure, PFMs activity and LUTS
of participants. Raters were unaware of
which group the participants belonged
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Randomised numbers in abstract (inter-
vention 16 + control 15) differ from num-
ber in figure 1 (of publication) (interven-
tion 18 + control 17); not clear when par-
ticipants dropped out but reasons for attri-
tion explained
Selective reporting (reporting bias) Unclear risk Table 1 (of publication) did not include the
18 and 17 randomised (2 completed the
study but refused post-test outcome mea-
suring)
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Other bias Low risk None detected.
Song 2013
Methods Design: multicentre RCT
Study dates: July 2009 to August 2012
Setting: China, inpatient and outpatient (4 centres)
Participants 204 men and women
Number and % women: intervention 82 (60.3%), control 39 (57.4%)
Age (mean): intervention 55 (SD 7) years, control 54 (SD 7) years
Diagnosed according to diagnostic criteria of 1995 NationalMeeting on Cerebrovascular
Accidents and meeting Urological criteria for incontinence. Type of stroke not reported.
Participants had incontinence with overflow and lack of voluntary control
Duration of incontinence (mean): intervention 31.2 (SD 22.3) days, range 11-165 days;
control 29.2 (SD 24.2) days, range 9-160 days
Inclusion criteria: stroke with involuntary UI with overflow incontinence, stable con-
dition, able to undergo investigations and treatment, no known cognitive impairment,
aged < 70 years, consenting
Exclusion criteria: incontinence not arising from stroke, incontinence pre-existing prior
to stroke, UTIs, cognitive impairment, severe heart/liver/kidney or other organ impair-
ments, other reasons including fainting at needles, allergy, impaired clotting that would
affect acupuncture, non-compliant to treatment, people with issues in diagnosis or mea-
surements
Interventions Intervention group: 136 participants. Acupuncture needles inserted atmultiple acupunc-
ture points (Qugu, Zhongji, Shuidao, Qihai, Baihui, Guanyuan, Sishenchong, Zhusanli,
Sanyinjiao, etc.) on the arms, legs and torso. Stainless steel needles 0.3 mm × 40 mm
were disinfected and inserted 25 mm, for 3minutes and repeatedly inserted 3 times every
5 minutes. The Zhusanli, sanyingjiao were given current at 1-10 Hz, 2-5 mV, using a
KWD808I machine, titrated up to participant’s tolerance. Given 5 times per week, for
2 weeks per session. 2 sessions were given (i.e. 4 weeks)
Control group: 68 participants. Indwelling catheter placedwith drainage every 2-4 hours.
Bladder washout performed once every 4 days. If any colour change or cloudiness noted,
washing done twice daily until normal. Washout with 0.9% normal saline 250 mL. If
inflammatory appearance or having long-term indwelling catheter, gentamicin 160,000
units was given. Solutions were placed for 1.5-2 hours, before draining from bladder.
Catheters changed every 2 weeks. Participants received bladder training in the morn-
ing, afternoon and evening: lower abdominal massage given (clockwise or anticlockwise
motions 300-500 rubs), and also Kegel exercises 15-20 times, each time holding for 2-
4 seconds. Catheters removed when the participants started to feel urge to pass urine.
Total duration 4 weeks
Outcomes Outcomes measured pre- and post-intervention (4 weeks)
Frequency, nocturia, intermittent stream, incontinence, postvoid volumes, participant
satisfaction
Funding source Not reported
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Declarations of interest among primary re-
searchers
None reported
Notes Imbalance in number of participants in each group. Study reported in Chinese and
translated into English
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number chart used.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit judge-
ment.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information. Some unex-
plained attrition in both groups
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk Assessment made on translated informa-
tion. Imbalance in number of participants
in each group
Tibaek 2005
Methods Design: prospective, randomised controlled and single-blinded parallel trial
Study dates: recruited Jan 1999 to March 2001
Setting: Copenhagen, Denmark. Outpatient Department of Geriatrics and Rheumatol-
ogy
Participants 26 women stroke survivors with mixed stress/urge UI
Age (median): 60 (IQR 56-74) years
Time since stroke: intervention group median 12 months (interquartile range 2-20),
control group median 13 months (interquartile range 2-50 months)
Inclusion criteria: women diagnosed with first ever ischaemic stroke according toWHO
definition and verified by CAT scan, stroke symptoms in at least 1month, normal cogni-
tive function (Mini-Mental State Examination score < 24), UI according to ICS defini-
tion, independent walking ability indoors > 100 m with or without aids, independence
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in toilet visits, aged 40-85 years
Exclusion criteria: UTI, symptom of vaginal prolapse, chronic respiratory diseases, psy-
chiatric diseases, other neurological diseases, unable to speak Danish
Interventions Intervention group: 14 participants. Systematic, controlled, intensive PFM training pro-
gramme. Programme consisted of: introduction to theory; home exercises, including
strength PFM exercise by performing close to maximum contraction (6-second contrac-
tion and 6-second rest), participants instructed to repeat exercise programme gradually
6-10 times in supine, standing and sitting positions, 1 or 2 times daily;
group treatment once per week, including isolating PFM contraction (6-second contrac-
tion and 6-second rest) and strength exercises (3-second contraction and 3-second rest,
and 6-second contraction and 6-second rest). All techniques were repeated 4-8 times
while supine, sitting and standing, and also prior to daily activities such as rising, sit-
ting and walking. Vaginal palpation performed to ensure correct contraction, to evaluate
contraction strength and to give feedback to participants
Control group: 12 participants. Normal, general rehabilitationwith no specific treatment
of UI
Outcomes Voiding diary measured: 2-day mean voiding frequency over 24 hours; 2-day mean day-
time voiding frequency; 2-day mean night-time voiding frequency; 3-day mean voiding
frequency over 24 hours; 3-day mean daytime voiding frequency; 3-day mean night-
time voiding frequency (post-intervention)
24 hour pad test measured: UI: 2-day mean number of incontinence episodes per 24
hours; 2-day mean number of used pads per 24 hours; 3-day mean number of incon-
tinence episodes per 24 hours; 3-day mean number of used pads per 24 hours (post-
intervention)
Vaginal palpation measured PFM function: mean function of PFM; mean strength
of PFM; mean static endurance of PFM; mean dynamic endurance of PFM (post-
intervention)
Quality of life measured by: SF-36 and IIQ (post-intervention and 6-month follow-up)
Funding source Grant sponsors: The Foundation of Danish Physiotherapists Research; The Foundation
of 1870, Direktor Jacob Madsen og hustrus Fond
Declarations of interest among primary re-
searchers
None reported
Notes No baseline differences in age, number of births or mobility between groups
Proportions for which data reported: 92% at post-intervention and 6 months
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised procedure using a mathemat-
ical table, conducted by a physiotherapist
who had no further involvement in study
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Allocation concealment (selection bias) Unclear risk Used sealed numbered envelopes but not
stated if they were sequentially numbered
and opaque
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants not blinded. Physiotherapist
delivering the 12-week intervention not
blinded. Outcome not likely to be influ-
enced by lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition reasons reported. Reasons for
missing data reported for participant ad-
ministered variables (0% to 21%). Reasons
not provided for missing data for investiga-
tor administered variables (0% to 4%)
Figure 2 (of publication): not clear how
many participants the results were for
Figure 3 (of publication): not clear if the
participant unable to do pretest PFM was
included in figure or excluded
Table V (of publication): only 11 interven-
tion participants reported
Selective reporting (reporting bias) Unclear risk Protocol not available.
Other bias Low risk None detected.
Tibaek 2017
Methods Design: experimental prospective RCT using randomised, controlled and single-blinded
parallel groups
Setting: Denmark, Outpatients
Participants 31 men
Age (mean): overall 68 years; intervention 68 (range 57-73) years, control: 70 (range 64-
75) years
Description of stroke and UI:
Ischaemic stroke: intervention 13 (87%), control 10 (76%)
Haemorrhagic stroke: intervention 0, control 2 (13%)
Time from stroke to trial entry (median): intervention 65 (IQR 50-87) days; control 55
(IQR 50-63) days
Inclusion criteria: men, diagnosed with stroke clinically defined according to the WHO
(1989) and confirmed by CT or MRI scan; ≥ 1 month since their last stroke; normal
cognitive function (Mini-Mental State Examination score > 25); LUTS according to
the ICS definition (Abrams 2002) with start or aggravation closely related to stroke and
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measured by DAN-PSS-1 questionnaire; ability to walk independently indoors for at
least 100 m with or without walking aids; outpatient and self-transported; ability to visit
the toilet independently aged > 18 years
Exclusion criteria: history of LUTS surgery, pelvic surgery or trauma; > 2 strokes (di-
agnosed at a hospital); other severe neurological disease including dementia; severe dys-
phasia; severe psychiatric disease; prostate cancer and not speaking Danish or English
Interventions Intervention: 16 participants. Systematic, controlled, intensive PFMT programme over
3 months (12 weekly sessions and 60 minutes per session) by the same specialised phys-
iotherapist. The treatment programme consisted of the following topics: introduction
(theory), home exercise, group treatment and digital anal palpation of PFMs
Control: 15 participants. Standard programme of general rehabilitation without any
specific treatment for LUTS
Outcomes Outcomes measured pretest, post-test (12 weeks) and at 6-month follow-up
Primary outcomes: DAN-PSS-1 questionnaire, 3-day voiding diary
Secondary outcomes: digital anal palpation of PFM
Health status: SF-36.
Funding source The authors disclosed receipt of the following financial support for the research, au-
thorship, publication (or a combination) of this article: “This study was supported by
grants from the Association of Danish Physiotherapists’ Research Foundation and Prac-
tice Foundation, the Foundation of 17.12.1981, Lykkefeldts Grant, the Foundation of
Lundbeck (UCSF) and the Department of Physiotherapy and Occupational Therapy
Glostrup Hospital, University of Copenhagen.”
Declarations of interest among primary re-
searchers
Authors declarednopotential conflicts of interestwith respect to the research, authorship,
publication (or a combination) of this article
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation based on a mathematical
table delivered in blocks of 10 in sealed en-
velopes and managed by a person who did
not participate further in study
Allocation concealment (selection bias) Unclear risk Unclear if envelopes were opaque.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Registration of variables from the pretest,
post-test and 6-month follow-up investi-
gation sequences were managed by phys-
iotherapists who were blinded to the ran-
domisation code of the participants, while
the physiotherapist treating the partici-
pants with PFMT was unblinded, Out-
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Tibaek 2017 (Continued)
come not likely to be affected by this lack
of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Registration of variables from the pretest,
post-test and follow-up investigation se-
quences were managed by physiotherapists
who were blinded to the randomisation
code of participants
Incomplete outcome data (attrition bias)
All outcomes
Low risk One dropout after randomisation in in-
tervention group. At 6-month follow-
up, 1 participant from the control group
dropped out. No reasons provided
Selective reporting (reporting bias) Unclear risk Protocol not available.
Other bias Low risk None detected.
Zhang 1996
Methods Design: RCT
Study dates: not reported
Setting: China, hospital Department of Internal Medicine
Participants 57 men and women
Age (range): elongated needle group 52-78 years; filiform needle group 53-76 years
Description of stroke and UI:
Cerebral haemorrhage: elongated needle group 15, filiform needle group 12
Cerebral infarction: elongated needle group 17, filiform needle group 13
Inclusion criteria: not reported.
Exclusion criteria: not reported.
Interventions Elongated needle group: 32 participants. Prone position. Following routine sterilisation,
2 gauge 30 elongated needles (7 Cun long) were inserted into bilateral Ciliao (BL 32)
at an angle of about 30 degrees with the skin, twirled and pushed forward slowly to
the greater sciatic foramen. When the needle was inserted into a depth of about 5
Cun and if the participant had sensations of tightness and distension, the insertion was
stopped immediately. This meant that the needle tip reached the back of the rectum and
the front of the sacrum. The needle was twirled in 1 direction and manipulated with
the uniform reinforcing and reducing method, causing the participant to have enough
needling sensation and feelings of raising and contraction in the anus, which displays the
success of needling. The needle was manipulated once every 10 minutes and retained
for 50 minutes
Filiform needle group: 25 participants. Lateral position. After local routine sterilisation,
Guanyan (CV 4), Zhongji (CV 3), Sanyinjiao (SP 6, both), Shenshu (BL 23) and
Pangguangshu (BL 28) were punctured with filiform needles 2 Cun long which advanced
to a depth of about 1.5 Cun. Following needling sensations achieved, needles were
manipulated with the uniform reinforcing and reducing method and then retained for
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50 minutes
All participants treated once daily. 6 days formed a therapeutic course, with 1 day of rest
between 2 courses. Total of 4 courses of treatment given
Outcomes Outcome measured after 4 courses of treatment (28 days).
Continent/incontinent, improvement in urinary symptoms.
Funding source Not reported
Declarations of interest among primary re-
searchers
Not reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “randomly divided.”
Allocation concealment (selection bias) Unclear risk Method of concealment not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data available for all participants.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias High risk No baseline assessment; unable to assess
similarity of participants between groups
Zhang 2002
Methods Design: RCT
Study dates: January 1999 to December 2001
Setting: unclear
Participants 38 male (59%) and 26 female (41%) adult stroke survivors with UI
Age (range): 42-62 years
29 participants hadmultiple cerebral infarctions; 14 had left-side basal ganglia infarction;
73Interventions for treating urinary incontinence after stroke in adults (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zhang 2002 (Continued)
9 had right-side basal ganglia infarction; 5 had frontal lobe infarction; 6 had parietal,
occipital or temporal lobe infarction; 1 had cerebellum infarction
Inclusion and exclusion: not reported
Interventions Intervention group: 36 participants. Acupuncture at the Tsusanli, Yinlingquan and Sany-
injiao points using 3-inch needle to acupuncture at the depth of 2-2.25 inches, 20 min-
utes per session, once per day for 7 times in the treatment period
Control group: 28 participants. Mannite and other medicines to do general treatment
with the partial foment on the bladder
Outcomes Time points not reported
Numbers not regaining continence
Funding source Not reported
Declarations of interest among primary re-
searchers
Not reported
Notes Study reported in Chinese and translated into English.
No description of baseline comparisons.
Trial was reported in a conference abstract.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Information not provided.
Allocation concealment (selection bias) Unclear risk Information not provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Information not provided.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results suggested all participants ac-
counted for and included in analysis
Selective reporting (reporting bias) Unclear risk Protocol not available.
Other bias Unclear risk Insufficient information reported/trans-
lated.
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Zhou 1999
Methods Design: RCT
Study dates: 1995
Setting: unclear
Participants 32 male (40%) and 48 female (60%) adult stroke survivors with UI
Age (range): 52-85 years
Inclusion and exclusion: not reported
Interventions Intervention A: 40 participants. Eye acupuncture and electriferous scalp acupuncture
once per day, 6 days per week for 4 weeks
Intervention B: 40 participants. Medication therapy, e.g. Hua Duo Zai shi tablet, Xi bi
lin, Nao fu kang, vitamins C and E
Outcomes Numbers not regaining continence
Funding source Not reported
Declarations of interest among primary re-
searchers
Not reported
Notes Study reported in Chinese and translated into English.
No description of baseline comparisons.
Trial reported in a conference abstract.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients are allocated using a sin-
gle-blind randomisation to the two groups.
”
Comment: no further description.
Allocation concealment (selection bias) Unclear risk Quote: “Patients are allocated using a sin-
gle-blind randomisation to the two groups.
”
Comment: no further description.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Quote: “Patients are allocated using a sin-
gle-blind randomisation to the two groups.
”
Comment: no further description.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data presented appeared complete.
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Zhou 1999 (Continued)
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk Insufficient information to allow judge-
ment. No inclusion or exclusion criteria re-
ported. No baseline reporting on equiva-
lence of groups
AUA: American Urological Association; CAT: computed axial tomography; CNP: continence nurse practitioner; CT: computed to-
mography; CTU: Clinical Trials Unit; DAN-PSS: Danish Prostatic Symptom Score; EQ-5D-5L: EuroQol Five-Dimensional Ques-
tionnaire; GP: general practitioner; ICIQ-UI-SF: International Consultation on Incontinence Questionnaire - Urinary Inconti-
nence Short Form; ICIQLUTSqol: International Consultation on Incontinence Questionnaire - Lower Urinary Tract Symptoms
Quality of Life questionnaire; ICS: International Continence Society; IIQ: Incontinence Impact Questionnaire; IQR: interquartile
range; LUTS: lower urinary tract symptom; MRI: magnetic resonance imaging; NHS: National Health Service; OABSS: Overactive
Bladder Symptom Score; PFM: pelvic floor muscle; PFMT: pelvic floor muscle training; RCT: randomised controlled trial; SD:
standard deviation; SF-36: 36-Item Short Form; SUFA: Society of Urodynamics; TENS: transcutaneous electrical nerve stimulation;
TPTNS: transcutaneous posterior tibial nerve stimulation; UI: urinary incontinence; UTI: urinary tract infection; WHO: World
Health Organization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Byles 2006 Study terminated due to poor recruitment. Study authors stated the study was abandoned
Cook 1998 Study did not include a measure of continence.
Engberg 2002 People with stroke were a subgroup but data not reported or available
EUCTR2009-009216-53-PT Study did not include people with stroke.
Gong 2013 Participants recruited were in the acute phase of stroke, which was not the type of participants under
investigation
Gousse 2007 Did not include people with stroke.
Gross 1990 Did not include a measure of continence.
Humphreys 2014 Did not include a measure of continence.
ISRCTN97151578 Unable to trace author or publications.
Kim 2003 Did not include people with stroke.
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Kuo 2007 People with stroke were a subgroup but data not reported or available
Madersbacher 2004 Did not include people with stroke.
Madersbacher 2005 Did not include people with stroke.
McDowell 1999 People with stroke were a subgroup but data not reported or available
Moon 2012 Did not include a measure of continence
NCT00213577 People with stroke were a subgroup but data not reported or available
NCT01275261 Study terminated. No data analysed (ClinicalTrials.gov).
Sakakibara 2008 People with stroke were a subgroup but data not reported or available
Shin 2016c Study terminated due to poor recruitment (ClinicalTrials.gov (NCT02472288))
Smilskalne 2009 Abstract of a completed study. No statistical data reported. We were unable to locate further publi-
cations from the study and were unable to trace the author for further details
Stohrer 2013 People with stroke were a subgroup but data not reported or available
Tekeoglu 1998 Did not directly test a method of promoting continence.
Thomas 2011 Participants recruited were in the acute phase of stroke, which was not the type of participants under
investigation
Vinsnes 2010 Did not include people with stroke.
Wikander 1998 Participants recruited were in the acute phase of stroke, which was not the type of participants under
investigation
Yun 2007 Participants recruited were in the acute phase of stroke, which was not the type of participants under
investigation. Study did not include a measure of continence
Zhu 2003 Participants recruited were in the acute phase of stroke, which was not the type of participants under
investigation
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Characteristics of studies awaiting assessment [ordered by study ID]
ACTRN12617000162314
Methods RCT
Participants Ischaemic stroke ≥ 6 months previously with UI, women, aged 40-75 years
Interventions PFMT vs usual care
Outcomes Primary outcome: resting and functional bioelectrical activity of PFM
Secondary outcome: subjective symptoms of UI by ICIQ
Notes Not yet recruited to trial.
ChiCTR-INR-16010239
Methods Randomised parallel controlled trial
Participants Aged 40-75 years with UI post-stroke. Onset of stroke within 30 days
Interventions Acupuncture vs computer intermediate frequency electrotherapy
Outcomes Residual urine volume, voided volume, urination time
Notes Estimated trial completion date: 31 December 2018
Wang 2014
Methods Multicentre, randomised, single-blind controlled clinical trial
Participants Adults aged 40-75 years, with urge UI occurring 4-48 weeks after stroke, diagnostic criteria according to ASA and
ICS
Interventions Traditional moxibustion therapy + routine care vs new type moxibustion therapy + routine care vs routine care
Outcomes Volume of micturition, frequency, nocturia, QoL, Barthel Index (Chinese version)
Notes Trial completed, results not published
ASA: American Stroke Association; ICIQ: International Consultation on Incontinence Questionnaire; ICS: International Continence
Society; PFMT: pelvic floor muscle training; QoL: quality of life; RCT: randomised controlled trial; UI: urinary incontinence.
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Characteristics of ongoing studies [ordered by study ID]
NCT02568774
Trial name or title Acupuncture on post-stroke overactive bladder: a randomized controlled trial
Methods RCT
Participants Aged ≥ 18 years, first or recurrent stroke with no previous incontinence
Interventions Acupuncture vs usual care
Outcomes Incontinent episodes, frequency daytime, frequency night-time, SS-QOL
Starting date August 2015
Contact information yeungwfj@hku.hk
Notes Estimated completion date: July 2018
Shin 2016b
Trial name or title Effectiveness and safety of electro-acupuncture on post-stroke urinary incontinence: study protocol of a pilot
multicentered, randomized, parallel, sham-controlled trial
Methods Pilot multicentred, randomised, parallel, sham-controlled trial
Participants Aged ≥ 19 years within 2 years of stroke occurrence, with ≥ 2 urinary frequencies and scoring 3 or 4 points
on the PPIUS or scoring 13 points on the K-IPSS
Interventions Electroacupuncture vs sham therapy
Outcomes Primary outcome: TUFS
Secondary outcomes: QoL (ICIQ-UI-SF), K-IPSS, LUTS
Starting date June 2016
Contact information mapsi@daum.net
Notes Recruitment completed 1 June 2017
ICIQ-UI-SF: International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form; LUTS: lower urinary
tract symptoms; K-IPSS: Korean version of International Prostate Symptom Score; PPIUS: Patient Perception of Intensity ofUrgency
Scale; RCT: randomised controlled trial; SS-QOL: Stroke Specific Quality of Life Scale; TUFS: total urgency and frequency score.
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D A T A A N D A N A L Y S E S
Comparison 1. Intervention versus no intervention/usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of participants
continent after treatment
6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Professional input
interventions
1 121 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.81, 2.02]
1.2 Complementary therapy
interventions
5 524 Risk Ratio (M-H, Random, 95% CI) 2.82 [1.57, 5.07]
2 Number of incontinent episodes
in 24 hours (mean)
4 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Behavioural interventions 1 18 Mean Difference (IV, Random, 95% CI) -1.0 [-2.74, 0.74]
2.2 Physical therapy
interventions
3 142 Mean Difference (IV, Random, 95% CI) -4.76 [-8.10, -1.41]
3 Number of participants cured of
all four urinary symptoms
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 Specialised professional
input interventions
1 143 Risk Ratio (M-H, Fixed, 95% CI) 1.55 [0.97, 2.48]
4 Urinary symptoms - frequency
(continuous variables)
6 Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 Behavioural interventions 2 48 Mean Difference (IV, Random, 95% CI) -1.71 [-3.02, -0.40]
4.2 Complementary therapy
interventions
1 62 Mean Difference (IV, Random, 95% CI) -5.57 [-7.00, -4.14]
4.3 Physical therapy
interventions
3 142 Mean Difference (IV, Random, 95% CI) -2.83 [-5.75, 0.09]
5 Urinary symptoms - frequency
(dichotomous variables)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Specialised professional
input interventions
1 187 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.82, 1.05]
6 Urinary symptoms - urgency 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Specialised professional
input interventions
1 188 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.89, 1.24]
7 Urinary symptoms - nocturia
(continuous variables)
5 Mean Difference (IV, Random, 95% CI) Subtotals only
7.1 Behavioural interventions 2 48 Mean Difference (IV, Random, 95% CI) -0.38 [-1.06, 0.29]
7.2 Complementary therapy
interventions
2 256 Mean Difference (IV, Random, 95% CI) -1.76 [-4.49, 0.96]
7.3 Physical therapy
interventions
1 61 Mean Difference (IV, Random, 95% CI) -1.52 [-1.73, -1.31]
8 Urinary symptoms - nocturia
(dichotomous variables)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8.1 Specialised professional
input interventions
1 186 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.86, 1.07]
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9 Physical measures: mean
function of the pelvic floor
muscle
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 Behavioural interventions 1 23 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.48, 0.68]
10 Health status and quality of life
- health status, mean total score
36-Item Short Form
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 Behavioural
interventions
1 24 Mean Difference (IV, Fixed, 95% CI) -28.0 [-169.66, 113.
66]
11 Health status and quality of life
- quality of life
2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
11.1 Behavioural
interventions
2 55 Std. Mean Difference (IV, Random, 95% CI) -0.99 [-2.83, 0.86]
12 Functional ability - mean
Barthel score (continuous
variables)
2 Mean Difference (IV, Random, 95% CI) Subtotals only
12.1 Physical therapy
interventions
2 81 Mean Difference (IV, Random, 95% CI) 8.97 [1.27, 16.68]
13 Participant satisfaction -
numbers who were dissatisfied
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
13.1 Specialised professional
input interventions
1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.17, 0.59]
Comparison 2. Intervention versus placebo
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of participants
continent after treatment
1 54 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.19, 3.04]
2 Number of incontinent episodes
- mean per day
1 39 Mean Difference (IV, Fixed, 95% CI) -1.10 [-3.99, 1.79]
3 Number of incontinent episodes
- mean per week
1 Paired samples mean (Random, 95% CI) -3.88 [-8.47, 0.70]
3.1 Oestrogen vs placebo
(mild incontinence)
1 Paired samples mean (Random, 95% CI) -1.71 [-3.51, 0.09]
3.2 Oestrogen vs placebo
(severe incontinence)
1 Paired samples mean (Random, 95% CI) -6.4 [-9.47, -3.33]
4 Health status and quality of life -
quality of life
1 30 Mean Difference (IV, Fixed, 95% CI) 3.90 [-4.25, 12.05]
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